{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:59:43Z","timestamp":1794650383041,"version":"4.9.1"},"reference-count":480,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770461"],"award-info":[{"award-number":["81770461"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.plipres.2021.101109","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T07:26:08Z","timestamp":1623396368000},"page":"101109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":227,"special_numbering":"C","title":["Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis"],"prefix":"10.1016","volume":"83","author":[{"given":"Heng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Ping","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0005","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"Chalasani","year":"2012","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2 Suppl 1","key":"10.1016\/j.plipres.2021.101109_bb0010","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0015","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2019.12.026","article-title":"Nonalcoholic fatty liver disease and fibrosis associated with increased risk of cardiovascular events in a prospective study","volume":"18","author":"Baratta","year":"2020","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb0030","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.plipres.2021.101109_bb0035","article-title":"NAFLD and cardiovascular diseases: a clinical review","author":"Kasper","year":"2020","journal-title":"Clin Res Cardiol: Off J German Cardiac Soc"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0040","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1210\/er.2003-0030","article-title":"Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones","volume":"25","author":"Payne","year":"2004","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.109.002014","article-title":"Xenobiotic, bile acid, and cholesterol transporters: function and regulation","volume":"62","author":"Klaassen","year":"2010","journal-title":"Pharmacol Rev"},{"issue":"1-2","key":"10.1016\/j.plipres.2021.101109_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2012.06.007","article-title":"Regulation of cholesterol homeostasis","volume":"368","author":"van der Wulp","year":"2013","journal-title":"Mol Cell Endocrinol"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb0055","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.bbadis.2015.05.015","article-title":"Recent insights on the role of cholesterol in non-alcoholic fatty liver disease","volume":"1852","author":"Arguello","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"15","key":"10.1016\/j.plipres.2021.101109_bb0060","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.129492","article-title":"The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis","volume":"4","author":"Mouchiroud","year":"2019","journal-title":"JCI insight"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0065","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrendo.2018.10","article-title":"Direct effects of thyroid hormones on hepatic lipid metabolism","volume":"14","author":"Sinha","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.plipres.2021.101109_bb0070","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ebiom.2018.04.009","article-title":"Activation of liver AMPK with PF-06409577 corrects NAFLD and lowers cholesterol in rodent and primate preclinical models","volume":"31","author":"Esquejo","year":"2018","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.plipres.2012.11.002","article-title":"Cholesterol metabolism and the pathogenesis of non-alcoholic steatohepatitis","volume":"52","author":"Musso","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.plipres.2021.101109_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1567-5688(15)50007-X","article-title":"The effect of ezetimibe on NAFLD","volume":"17","author":"Averna","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/j.plipres.2021.101109_bb0085","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2019.02.028","article-title":"Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes","volume":"284","author":"Nascimbeni","year":"2019","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0090","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0095","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41575-018-0082-x","article-title":"The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis","volume":"16","author":"Kazankov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0100","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.09.049","article-title":"A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells","volume":"142","author":"Teratani","year":"2012","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0105","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0035-1550060","article-title":"Emerging and disease-specific mechanisms of hepatic stellate cell activation","volume":"35","author":"Wallace","year":"2015","journal-title":"Semin Liver Dis"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19072034","article-title":"New aspects of lipotoxicity in nonalcoholic steatohepatitis","volume":"19","author":"Mendez-Sanchez","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0115","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1002\/hep.23719","article-title":"Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites","volume":"52","author":"Neuschwander-Tetri","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb0120","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.tem.2015.07.006","article-title":"Ceramides - lipotoxic inducers of metabolic disorders","volume":"26","author":"Chaurasia","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"39","key":"10.1016\/j.plipres.2021.101109_bb0125","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.1073\/pnas.1113359108","article-title":"Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease","volume":"108","author":"Kumashiro","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb0130","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.plipres.2021.101109_bb0135","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3333","article-title":"Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance","volume":"36","author":"Fiorentino","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0145","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000011","article-title":"Impact of non-alcoholic fatty liver disease on cardiovascular outcomes in patients with stable coronary artery disease: A matched case-control study","volume":"10","author":"Liu","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0150","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0155","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cgh.2011.12.039","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population","volume":"10","author":"Stepanova","year":"2012","journal-title":"Clin Gastroenterol Hepatol: Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0160","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/hep.23314","article-title":"Decreased survival of subjects with elevated liver function tests during a 28-year follow-up","volume":"51","author":"S\u00f6derberg","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.plipres.2021.101109_bb0165","doi-asserted-by":"crossref","first-page":"33386","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002578","article-title":"Nonalcoholic fatty liver disease for identification of preclinical carotid atherosclerosis","volume":"95","author":"Sinn","year":"2016","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb0175","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.tem.2019.08.008","article-title":"NAFLD and atherosclerosis: two sides of the same dysmetabolic coin?","volume":"30","author":"Stols-Gon\u00e7alves","year":"2019","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.plipres.2021.101109_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12944-016-0221-8","article-title":"Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review","volume":"15","author":"Li","year":"2016","journal-title":"Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0185","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2015.11.008","article-title":"The role of cholesterol in the pathogenesis of NASH","volume":"27","author":"Ioannou","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/nu12072021","article-title":"Impact of cholesterol metabolism in immune cell function and atherosclerosis","volume":"12","author":"Aguilar-Ballester","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.plipres.2021.101109_bb0195","doi-asserted-by":"crossref","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metabol"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1055\/s-0032-1306423","article-title":"Dyslipidemia in patients with nonalcoholic fatty liver disease","volume":"32","author":"Chatrath","year":"2012","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0205","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1194\/jlr.P090449","article-title":"PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients","volume":"60","author":"Dongiovanni","year":"2019","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11883-020-0820-8","article-title":"Non-alcoholic fatty liver disease and its links with inflammation and atherosclerosis","volume":"22","author":"Abdallah","year":"2020","journal-title":"Curr Atheroscler Rep"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5519","key":"10.1016\/j.plipres.2021.101109_bb0220","doi-asserted-by":"crossref","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science (New York, NY)"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0225","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/emboj\/19.5.819","article-title":"Crystal structure of the catalytic portion of human HMG-CoA reductase: insights into regulation of activity and catalysis","volume":"19","author":"Istvan","year":"2000","journal-title":"EMBO J"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23030580","article-title":"Phenolic compounds from belamcanda Chinensis seeds","volume":"23","author":"Song","year":"2018","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0235","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cmet.2017.06.019","article-title":"Ancillary activity: Beyond core metabolism in immune cells","volume":"26","author":"Puleston","year":"2017","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0240","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/S0021-9258(18)89764-2","article-title":"Domain structure of 3-hydroxy-3-methylglutaryl coenzyme A reductase, a glycoprotein of the endoplasmic reticulum","volume":"260","author":"Liscum","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2021.101109_bb0245","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1146\/annurev.genet.41.110306.130315","article-title":"Regulation of sterol synthesis in eukaryotes","volume":"41","author":"Espenshade","year":"2007","journal-title":"Annu Rev Genet"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0250","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.atherosclerosis.2007.12.004","article-title":"Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER","volume":"200","author":"Polisecki","year":"2008","journal-title":"Atherosclerosis"},{"issue":"33","key":"10.1016\/j.plipres.2021.101109_bb0255","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.2174\/092986711797636081","article-title":"Functional non-synonymous polymorphisms prediction methods: current approaches and future developments","volume":"18","author":"Gonzalez-Castejon","year":"2011","journal-title":"Curr Med Chem"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0260","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/hep.21763","article-title":"A lipidomic analysis of nonalcoholic fatty liver disease","volume":"46","author":"Puri","year":"2007","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0265","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0270","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/hep.26088","article-title":"Cholesterol and nonalcoholic fatty liver disease: renewed focus on an old villain","volume":"56","author":"Kerr","year":"2012","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0275","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int J Mol Med"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0280","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2337\/db19-0076","article-title":"Myeloid HMG-CoA reductase determines adipose tissue inflammation, insulin resistance, and hepatic steatosis in diet-induced obese mice","volume":"69","author":"Takei","year":"2020","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0285","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1039\/C7FO00103G","article-title":"Sulfated polysaccharides from Enteromorpha prolifera suppress SREBP-2 and HMG-CoA reductase expression and attenuate non-alcoholic fatty liver disease induced by a high-fat diet","volume":"8","author":"Ren","year":"2017","journal-title":"Food Funct"},{"key":"10.1016\/j.plipres.2021.101109_bb0290","doi-asserted-by":"crossref","unstructured":"D.I. Swerdlow, D. Preiss, K.B. Kuchenbaecker, M.V. Holmes, J.E. Engmann, T. Shah, R. Sofat, S. Stender, P.C. Johnson, R.A. Scott, M. Leusink, N. Verweij, S.J. Sharp, Y. Guo, C. Giambartolomei, C. Chung, A. Peasey, A. Amuzu, K. Li, J. Palmen, P. Howard, J.A. Cooper, F. Drenos, Y.R. Li, G. Lowe, J. Gallacher, M.C. Stewart, I. Tzoulaki, S.G. Buxbaum, A.D. Van Der, N.G. Forouhi, N.C. Onland Moret, Y.T. van der Schouw, R.B. Schnabel, J.A. Hubacek, R. Kubinova, M. Baceviciene, A. Tamosiunas, A. Pajak, R. Topor-Madry, U. Stepaniak, S. Malyutina, D. Baldassarre, B. Sennblad, E. Tremoli, U. de Faire, F. Veglia, I. Ford, J.W. Jukema, R.G. Westendorp, G.J. de Borst, P.A. de Jong, A. Algra, W. Spiering, A.H. Maitland van der Zee, O.H. Klungel, A. de Boer, P.A. Doevendans, C.B. Eaton, J.G. Robinson, D. Duggan, J. Kjekshus, J.R. Downs, A.M. Gotto, A.C. Keech, R. Marchioli, G. Tognoni, P.S. Sever, N.R. Poulter, D.D. Waters, T.R. Pedersen, P. Amarenco, H. Nakamura, J.J. McMurray, J.D. Lewsey, D.I. Chasman, P.M. Ridker, A.P. Maggioni, L. Tavazzi, K.K. Ray, S.R. Seshasai, J.E. Manson, J.F. Price, P.H. Whincup, R.W. Morris, D.A. Lawlor, G.D. Smith, Y. Ben-Shlomo, P.J. Schreiner, M. Fornage, D.S. Siscovick, M. Cushman, M. Kumari, N.J. Wareham, W.M. Verschuren, S. Redline, S.R. Patel, J.C. Whittaker, A. Hamsten, J.A. Delaney, C. Dale, T.R. Gaunt, A. Wong, D. Kuh, R. Hardy, S. Kathiresan, B.A. Castillo, P. van der Harst, E.J. Brunner, A. Tybjaerg-Hansen, M.G. Marmot, R.M. Krauss, M. Tsai, J. Coresh, R.C. Hoogeveen, B.M. Psaty, L.A. Lange, H. Hakonarson, F. Dudbridge, S.E. Humphries, P.J. Talmud, M. Kivim\u00e4ki, N.J. Timpson, C. Langenberg, F.W. Asselbergs, M. Voevoda, M. Bobak, H. Pikhart, J.G. Wilson, A.P. Reiner, B.J. Keating, A.D. Hingorani, N. Sattar, HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials, Lancet (Lond, Engl) 385(9965) (2015) 351-61.","DOI":"10.1016\/S0140-6736(14)61183-1"},{"issue":"13","key":"10.1016\/j.plipres.2021.101109_bb0295","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: A meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"Jama"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0300","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2004.09.004","article-title":"Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management","volume":"177","author":"Kajinami","year":"2004","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb0305","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/gb-2004-5-11-248","article-title":"The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases","volume":"5","author":"Friesen","year":"2004","journal-title":"Genome Biol"},{"issue":"22","key":"10.1016\/j.plipres.2021.101109_bb0310","doi-asserted-by":"crossref","first-page":"19933","DOI":"10.1074\/jbc.M213006200","article-title":"Crystal structure of a statin bound to a class II hydroxymethylglutaryl-CoA reductase","volume":"278","author":"Tabernero","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FPC.0000000000000178","article-title":"Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia","volume":"26","author":"Leduc","year":"2016","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0320","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0163-7827(01)00010-8","article-title":"Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes","volume":"40","author":"Shimano","year":"2001","journal-title":"Prog Lipid Res"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb0325","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0330","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.molcel.2004.06.019","article-title":"Direct binding of cholesterol to the purified membrane region of SCAP: mechanism for a sterol-sensing domain","volume":"15","author":"Radhakrishnan","year":"2004","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0335","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cmet.2008.10.008","article-title":"Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance","volume":"8","author":"Radhakrishnan","year":"2008","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0340","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0092-8674(02)00872-3","article-title":"Crucial step in cholesterol homeostasis: sterols promote binding of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs in ER","volume":"110","author":"Yang","year":"2002","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0345","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1097-2765(02)00591-9","article-title":"Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism","volume":"10","author":"Brown","year":"2002","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0350","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.29206","article-title":"A novel role for CRTC2 in hepatic cholesterol synthesis through SREBP-2","volume":"66","author":"Li","year":"2017","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.plipres.2021.101109_bb0355","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.freeradbiomed.2018.12.016","article-title":"Mitochondrial aquaporin-8 is involved in SREBP-controlled hepatocyte cholesterol biosynthesis","volume":"131","author":"Danielli","year":"2019","journal-title":"Free Radic Biol Med"},{"issue":"1-2","key":"10.1016\/j.plipres.2021.101109_bb0360","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11010-018-3324-x","article-title":"Epigallocatechin gallate suppresses hepatic cholesterol synthesis by targeting SREBP-2 through SIRT1\/FOXO1 signaling pathway","volume":"448","author":"Li","year":"2018","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0365","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11745-014-3983-7","article-title":"The safety and anti-hypercholesterolemic effect of coptisine in Syrian golden hamsters","volume":"50","author":"He","year":"2015","journal-title":"Lipids"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb0370","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s00018-009-9018-5","article-title":"Digoxin and ouabain increase the synthesis of cholesterol in human liver cells","volume":"66","author":"Campia","year":"2009","journal-title":"Cell Mol Life Sci: CMLS"},{"issue":"5\u20136","key":"10.1016\/j.plipres.2021.101109_bb0375","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1159\/000185525","article-title":"Transcriptional regulation of HMG-CoA synthase and HMG-CoA reductase genes by human ACBP","volume":"22","author":"Vock","year":"2008","journal-title":"Cell Physiol Biochem: Int J Exper Cell Physiol Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0380","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/aps.2016.158","article-title":"Dicer1\/miR-29\/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis","volume":"38","author":"Liu","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0385","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1161\/ATVBAHA.117.309247","article-title":"Human MicroRNA-548p decreases hepatic apolipoprotein B secretion and lipid synthesis","volume":"37","author":"Zhou","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2021.101109_bb0390","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2199-13-29","article-title":"A novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) splice variant with an alternative exon 1 potentially encoding an extended N-terminus","volume":"13","author":"Stormo","year":"2012","journal-title":"BMC Mol Biol"},{"issue":"26","key":"10.1016\/j.plipres.2021.101109_bb0395","doi-asserted-by":"crossref","first-page":"18707","DOI":"10.1074\/jbc.R113.479808","article-title":"Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR)","volume":"288","author":"Sharpe","year":"2013","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0400","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/hmg\/ddt422","article-title":"HNRNPA1 regulates HMGCR alternative splicing and modulates cellular cholesterol metabolism","volume":"23","author":"Yu","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"14","key":"10.1016\/j.plipres.2021.101109_bb0405","first-page":"3106","article-title":"SUGP1 is a novel regulator of cholesterol metabolism","volume":"25","author":"Kim","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0410","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.cmet.2008.09.004","article-title":"Insig regulates HMG-CoA reductase by controlling enzyme phosphorylation in fission yeast","volume":"8","author":"Burg","year":"2008","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0415","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.plipres.2011.07.002","article-title":"Regulation of HMG-CoA reductase in mammals and yeast","volume":"50","author":"Burg","year":"2011","journal-title":"Prog Lipid Res"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0420","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/hep4.1279","article-title":"Inhibition of adenosine monophosphate-activated protein kinase-3-hydroxy-3-methylglutaryl coenzyme a reductase signaling leads to hypercholesterolemia and promotes hepatic steatosis and insulin resistance","volume":"3","author":"Loh","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.plipres.2021.101109_bb0425","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejmech.2014.07.107","article-title":"Activated AMPK explains hypolipidemic effects of sulfated low molecular weight guluronate on HepG2 cells","volume":"85","author":"Liu","year":"2014","journal-title":"Eur J Med Chem"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0430","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4062\/biomolther.2012.20.2.220","article-title":"Pectinase-processed ginseng radix (GINST) ameliorates hyperglycemia and hyperlipidemia in high fat diet-fed ICR mice","volume":"20","author":"Yuan","year":"2012","journal-title":"Biomol Ther"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb0435","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1111\/1750-3841.13828","article-title":"Inhibition of Cholesterol Synthesis in HepG2 Cells by GINST-Decreasing HMG-CoA Reductase Expression Via AMP-Activated Protein Kinase","volume":"82","author":"Han","year":"2017","journal-title":"J Food Sci"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0440","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1194\/jlr.M047654","article-title":"Thyroid-stimulating hormone decreases HMG-CoA reductase phosphorylation via AMP-activated protein kinase in the liver","volume":"56","author":"Zhang","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2021.101109_bb0445","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.semcdb.2017.10.019","article-title":"Underlying mechanisms for sterol-induced ubiquitination and ER-associated degradation of HMG CoA reductase","volume":"81","author":"Johnson","year":"2018","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0450","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1074\/jbc.M706967200","article-title":"Effectors of rapid homeostatic responses of endoplasmic reticulum cholesterol and 3-hydroxy-3-methylglutaryl-CoA reductase","volume":"283","author":"Lange","year":"2008","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0455","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cmet.2005.01.001","article-title":"Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol","volume":"1","author":"Song","year":"2005","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0460","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/cr.2008.61","article-title":"Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase","volume":"18","author":"DeBose-Boyd","year":"2008","journal-title":"Cell Res"},{"issue":"51","key":"10.1016\/j.plipres.2021.101109_bb0465","doi-asserted-by":"crossref","first-page":"20503","DOI":"10.1073\/pnas.1112831108","article-title":"Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8","volume":"108","author":"Jo","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0470","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.molcel.2005.08.009","article-title":"Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase","volume":"19","author":"Song","year":"2005","journal-title":"Mol Cell"},{"issue":"23","key":"10.1016\/j.plipres.2021.101109_bb0475","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.1091\/mbc.e12-08-0631","article-title":"Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system","volume":"23","author":"Tsai","year":"2012","journal-title":"Mol Biol Cell"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb0480","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1074\/jbc.RA117.001260","article-title":"Ring finger protein 145 (RNF145) is a ubiquitin ligase for sterol-induced degradation of HMG-CoA reductase","volume":"293","author":"Jiang","year":"2018","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0485","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1038\/s41467-018-07590-3","article-title":"Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol","volume":"9","author":"Jiang","year":"2018","journal-title":"Nat Commun"},{"issue":"50","key":"10.1016\/j.plipres.2021.101109_bb0490","doi-asserted-by":"crossref","first-page":"21424","DOI":"10.1073\/pnas.1011859107","article-title":"Identification of Ubxd8 protein as a sensor for unsaturated fatty acids and regulator of triglyceride synthesis","volume":"107","author":"Lee","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb0495","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/ATVBAHA.117.310002","article-title":"Haploid mammalian genetic screen identifies UBXD8 as a key determinant of hmgcr degradation and cholesterol biosynthesis","volume":"37","author":"Loregger","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0500","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbamcr.2011.09.006","article-title":"Regulation of p97 in the ubiquitin-proteasome system by the UBX protein-family","volume":"1823","author":"Kloppsteck","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"27","key":"10.1016\/j.plipres.2021.101109_bb0505","doi-asserted-by":"crossref","first-page":"19053","DOI":"10.1074\/jbc.M114.576652","article-title":"Sequential actions of the AAA-ATPase valosin-containing protein (VCP)\/p97 and the proteasome 19 S regulatory particle in sterol-accelerated, endoplasmic reticulum (ER)-associated degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase","volume":"289","author":"Morris","year":"2014","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.05.020","article-title":"Structure of the human lipid exporter ABCA1","volume":"169","author":"Qian","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb0515","doi-asserted-by":"crossref","first-page":"10119","DOI":"10.1074\/jbc.M300137200","article-title":"The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways","volume":"278","author":"Kiss","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0520","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0006-291X(02)02274-X","article-title":"The ABCA1 transporter functions on the basolateral surface of hepatocytes","volume":"297","author":"Neufeld","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"47","key":"10.1016\/j.plipres.2021.101109_bb0525","doi-asserted-by":"crossref","first-page":"43564","DOI":"10.1074\/jbc.M107938200","article-title":"Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes\/lysosomes","volume":"276","author":"Chen","year":"2001","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.plipres.2021.101109_bb0530","doi-asserted-by":"crossref","first-page":"11358","DOI":"10.1073\/pnas.96.20.11358","article-title":"Cholesterol efflux to apolipoprotein AI involves endocytosis and resecretion in a calcium-dependent pathway","volume":"96","author":"Takahashi","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb0535","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1161\/01.ATV.0000075912.83860.26","article-title":"Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux","volume":"23","author":"Wang","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"42","key":"10.1016\/j.plipres.2021.101109_bb0540","doi-asserted-by":"crossref","first-page":"33053","DOI":"10.1074\/jbc.M005438200","article-title":"Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0545","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1194\/jlr.M300355-JLR200","article-title":"ABCA1 and amphipathic apolipoproteins form high-affinity molecular complexes required for cholesterol efflux","volume":"45","author":"Fitzgerald","year":"2004","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0550","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/jgh.12430","article-title":"Apolipoprotein A-I and adenosine triphosphate-binding cassette transporter A1 expression alleviates lipid accumulation in hepatocytes","volume":"29","author":"Liu","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0555","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbrc.2018.03.003","article-title":"Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C delta pathway","volume":"498","author":"Liang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2021.101109_bb0560","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.molmet.2019.12.015","article-title":"Role of ATP-binding cassette transporter A1 in suppressing lipid accumulation by glucagon-like peptide-1 agonist in hepatocytes","volume":"34","author":"Lyu","year":"2020","journal-title":"Mol Metabol"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb0565","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/liv.13109","article-title":"Hepatic miR-33a\/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects","volume":"36","author":"Vega-Badillo","year":"2016","journal-title":"Liver Int: Off J Int Assoc Study Liver"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb0570","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.metabol.2015.07.014","article-title":"Increased expression of ATP-binding cassette transporter A1 (ABCA1) as a possible mechanism for the protective effect of cilostazol against hepatic steatosis","volume":"64","author":"Jeon","year":"2015","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.plipres.2021.101109_bb0575","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.fct.2013.07.048","article-title":"The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease","volume":"60","author":"Jung","year":"2013","journal-title":"Food Chem Toxicol: Int J Publ Br Indus Bioll Res Assoc"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0580","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/j.1440-1746.2011.06986.x","article-title":"Inflammatory stress exacerbates hepatic cholesterol accumulation via disrupting cellular cholesterol export","volume":"27","author":"Chen","year":"2012","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0585","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hep.22423","article-title":"Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice","volume":"48","author":"Ma","year":"2008","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb0590","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/cvr\/cvy077","article-title":"Identification of miR-9-5p as direct regulator of ABCA1 and HDL-driven reverse cholesterol transport in circulating CD14+ cells of patients with metabolic syndrome","volume":"114","author":"D'Amore","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0595","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.metabol.2012.11.006","article-title":"The R230C variant of the ATP binding cassette protein A1 (ABCA1) gene is associated with a decreased response to glyburide therapy in patients with type 2 diabetes mellitus","volume":"62","author":"Aguilar-Salinas","year":"2013","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.plipres.2021.101109_bb0600","doi-asserted-by":"crossref","first-page":"639524","DOI":"10.3389\/fendo.2021.639524","article-title":"ABCA1 69C>T polymorphism and the risk of type 2 diabetes mellitus: a systematic review and updated meta-analysis","volume":"12","author":"Yoon","year":"2021","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0605","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/ijerph13020220","article-title":"Association between polymorphisms and haplotype in the ABCA1 gene and overweight\/obesity patients in the uyghur population of China","volume":"13","author":"Yao","year":"2016","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0610","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.012587699","article-title":"The ATP binding cassette transporter A1 (ABCA1) modulates the development of aortic atherosclerosis in C57BL\/6 and apoE-knockout mice","volume":"99","author":"Joyce","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0615","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1172\/JCI0215748","article-title":"Increased ABCA1 activity protects against atherosclerosis","volume":"110","author":"Singaraja","year":"2002","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0620","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1194\/jlr.M400506-JLR200","article-title":"Complete functional rescue of the ABCA1-\/- mouse by human BAC transgenesis","volume":"46","author":"Coutinho","year":"2005","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0625","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI200112517","article-title":"ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice","volume":"108","author":"Vaisman","year":"2001","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0630","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1194\/jlr.M200414-JLR200","article-title":"Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations","volume":"44","author":"Basso","year":"2003","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0635","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/cvr\/cvq204","article-title":"Hepatocyte-specific ABCA1 transfer increases HDL cholesterol but impairs HDL function and accelerates atherosclerosis","volume":"88","author":"Feng","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0640","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1161\/ATVBAHA.108.182303","article-title":"Tissue-specific roles of ABCA1 influence susceptibility to atherosclerosis","volume":"29","author":"Brunham","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"44","key":"10.1016\/j.plipres.2021.101109_bb0645","doi-asserted-by":"crossref","first-page":"33053","DOI":"10.1074\/jbc.M604526200","article-title":"ABCA1 overexpression in the liver of LDLr-KO mice leads to accumulation of pro-atherogenic lipoproteins and enhanced atherosclerosis","volume":"281","author":"Joyce","year":"2006","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb0650","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1161\/ATVBAHA.112.301110","article-title":"Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis","volume":"33","author":"Bi","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb0655","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1194\/jlr.M300110-JLR200","article-title":"Alterations of plasma lipids in mice via adenoviral-mediated hepatic overexpression of human ABCA1","volume":"44","author":"Wellington","year":"2003","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0660","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1172\/JCI200523915","article-title":"Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I","volume":"115","author":"Timmins","year":"2005","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb0665","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/01.ATV.0000229219.13757.a2","article-title":"Hepatic ATP-binding cassette transporter A1 is a key molecule in high-density lipoprotein cholesteryl ester metabolism in mice","volume":"26","author":"Singaraja","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9841","key":"10.1016\/j.plipres.2021.101109_bb0670","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet (Lond, Engl)"},{"issue":"6278","key":"10.1016\/j.plipres.2021.101109_bb0675","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science (New York, NY)"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb0680","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1172\/JCI42946","article-title":"Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease","volume":"121","author":"Besler","year":"2011","journal-title":"J Clin Invest"},{"issue":"21","key":"10.1016\/j.plipres.2021.101109_bb0685","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb0690","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/nm.2930","article-title":"The not-so-simple HDL story: A new era for quantifying HDL and cardiovascular risk?","volume":"18","author":"Heinecke","year":"2012","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0695","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrcardio.2010.222","article-title":"HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms","volume":"8","author":"Navab","year":"2011","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb0700","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1161\/01.ATV.0000166616.86723.d0","article-title":"Knockdown of hepatic ABCA1 by RNA interference decreases plasma HDL cholesterol levels and influences postprandial lipemia in mice","volume":"25","author":"Ragozin","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb0705","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1161\/01.RES.0000170946.56981.5c","article-title":"New insights into the regulation of HDL metabolism and reverse cholesterol transport","volume":"96","author":"Lewis","year":"2005","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb0710","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/ATVBAHA.119.312382","article-title":"Targeted deletion of hepatocyte Abca1 increases plasma HDL (High-Density Lipoprotein) reverse cholesterol transport via the LDL (Low-Density Lipoprotein) receptor","volume":"39","author":"Bashore","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2021.101109_bb0715","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2018.03.010","article-title":"AIBP reduces atherosclerosis by promoting reverse cholesterol transport and ameliorating inflammation in apoE(-\/-) mice","volume":"273","author":"Zhang","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2021.101109_bb0720","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2017.06.015","article-title":"Hsp27 promotes ABCA1 expression and cholesterol efflux through the PI3K\/PKCzeta\/Sp1 pathway in THP-1 macrophages","volume":"810","author":"Kuang","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.plipres.2021.101109_bb0725","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejphar.2017.05.055","article-title":"Puerarin promotes ABCA1-mediated cholesterol efflux and decreases cellular lipid accumulation in THP-1 macrophages","volume":"811","author":"Li","year":"2017","journal-title":"Eur J Pharmacol"},{"issue":"Suppl","key":"10.1016\/j.plipres.2021.101109_bb0730","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1194\/jlr.R800088-JLR200","article-title":"The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis","volume":"50","author":"Rader","year":"2009","journal-title":"J Lipid Res"},{"issue":"21","key":"10.1016\/j.plipres.2021.101109_bb0735","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0740","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2009.04.002","article-title":"Where are we with probucol: a new life for an old drug?","volume":"207","author":"Yamashita","year":"2009","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb0745","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.110.009704","article-title":"Pharmacologic suppression of hepatic ATP-binding cassette transporter 1 activity in mice reduces high-density lipoprotein cholesterol levels but promotes reverse cholesterol transport","volume":"124","author":"Yamamoto","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0750","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00795-017-0166-7","article-title":"Increased hepatic ABCA1 transporter is associated with hypercholesterolemia in a cholestatic rat model and primary biliary cholangitis patients","volume":"50","author":"Takeyama","year":"2017","journal-title":"Med Mol Morphol"},{"issue":"36","key":"10.1016\/j.plipres.2021.101109_bb0755","doi-asserted-by":"crossref","first-page":"28240","DOI":"10.1074\/jbc.M003337200","article-title":"Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor\/retinoid X receptor","volume":"275","author":"Costet","year":"2000","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb0760","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1253\/circj.CJ-11-1338","article-title":"Interleukin-18 and interleukin-12 together downregulate ATP-binding cassette transporter A1 expression through the interleukin-18R\/nuclear factor-kappaB signaling pathway in THP-1 macrophage-derived foam cells","volume":"76","author":"Yu","year":"2012","journal-title":"Circul J: Off J Jpn Circul Soc"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb0765","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1038\/nm1102-1243","article-title":"The liver X receptor gene team: potential new players in atherosclerosis","volume":"8","author":"Repa","year":"2002","journal-title":"Nat Med"},{"issue":"Pt 2","key":"10.1016\/j.plipres.2021.101109_bb0770","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.fct.2016.12.017","article-title":"Effects of tetramethylpyrazine from Chinese black vinegar on antioxidant and hypolipidemia activities in HepG2 cells","volume":"109","author":"Chen","year":"2017","journal-title":"Food Chem Toxicol: Int J Publ Br Indus Biol Res Assoc"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb0775","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1161\/ATVBAHA.115.306132","article-title":"Vitamin D protects against atherosclerosis via regulation of cholesterol efflux and macrophage polarization in hypercholesterolemic swine","volume":"35","author":"Yin","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0780","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1194\/jlr.M020917","article-title":"Niacin increases HDL biogenesis by enhancing DR4-dependent transcription of ABCA1 and lipidation of apolipoprotein A-I in HepG2 cells","volume":"53","author":"Zhang","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2021.101109_bb0785","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2018.02.027","article-title":"Interleukin-32 upregulates the expression of ABCA1 and ABCG1 resulting in reduced intracellular lipid concentrations in primary human hepatocytes","volume":"271","author":"Damen","year":"2018","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0790","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bbrc.2010.10.053","article-title":"PPARgamma activates ABCA1 gene transcription but reduces the level of ABCA1 protein in HepG2 cells","volume":"402","author":"Mogilenko","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"48","key":"10.1016\/j.plipres.2021.101109_bb0795","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1093\/eurheartj\/ehx315","article-title":"TRAK2, a novel regulator of ABCA1 expression, cholesterol efflux and HDL biogenesis","volume":"38","author":"Lake","year":"2017","journal-title":"Eur Heart J"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0800","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.bbrc.2005.04.071","article-title":"Pregnane X receptor-agonists down-regulate hepatic ATP-binding cassette transporter A1 and scavenger receptor class B type I","volume":"331","author":"Sporstol","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0805","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1161\/ATVBAHA.111.238360","article-title":"HNF4alpha increases liver-specific human ATP-binding cassette transporter A1 expression and cholesterol efflux to apolipoprotein A-I in response to cholesterol depletion","volume":"32","author":"Ohoka","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0810","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bbagrm.2014.04.021","article-title":"Novel mechanism of transcriptional repression of the human ATP binding cassette transporter A1 gene in hepatic cells by the winged helix\/forkhead box transcription factor A2","volume":"1839","author":"Thymiakou","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0815","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1161\/ATVBAHA.114.305182","article-title":"Cellular cholesterol accumulation facilitates ubiquitination and lysosomal degradation of cell surface-resident ABCA1","volume":"35","author":"Mizuno","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0820","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/hep.24387","article-title":"Ubiquitination is associated with lysosomal degradation of cell surface-resident ATP-binding cassette transporter A1 (ABCA1) through the endosomal sorting complex required for transport (ESCRT) pathway","volume":"54","author":"Mizuno","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.plipres.2021.101109_bb0825","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jinorgbio.2018.09.016","article-title":"Cadmium induced redistribution of cholesterol by upregulating ABCA1 and downregulating OSBP","volume":"189","author":"Wang","year":"2018","journal-title":"J Inorg Biochem"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0830","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062667","article-title":"Inhibition of mitogen-activated protein kinase Erk1\/2 promotes protein degradation of ATP binding cassette transporters A1 and G1 in CHO and HuH7 cells","volume":"8","author":"Mulay","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0835","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.28391","article-title":"A novel long noncoding RNA Lnc-HC binds hnRNPA2B1 to regulate expressions of Cyp7a1 and Abca1 in hepatocytic cholesterol metabolism","volume":"64","author":"Lan","year":"2016","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0840","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s42255-018-0004-9","article-title":"The long noncoding RNA CHROME regulates cholesterol homeostasis in primate","volume":"1","author":"Hennessy","year":"2019","journal-title":"Nat Metab"},{"issue":"5985","key":"10.1016\/j.plipres.2021.101109_bb0845","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science (New York, NY)"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb0850","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/CIRCRESAHA.112.300648","article-title":"MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor","volume":"112","author":"de Aguiar Vallim","year":"2013","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0855","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2014.02.008","article-title":"MicroRNA-27a\/b regulates cellular cholesterol efflux, influx and esterification\/hydrolysis in THP-1 macrophages","volume":"234","author":"Zhang","year":"2014","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0860","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1159\/000494235","article-title":"Glucagon-like peptide-1 modulates cholesterol homeostasis by suppressing the miR-19b-induced downregulation of ABCA1","volume":"50","author":"Yao","year":"2018","journal-title":"Cell Physiol Biochem: Int J Exper Cell Physiol Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0865","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.bbrc.2018.02.126","article-title":"Glucagon-like peptide-1 contributes to increases ABCA1 expression by downregulating miR-758 to regulate cholesterol homeostasis","volume":"497","author":"Yao","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb0870","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1161\/ATVBAHA.113.302004","article-title":"Regulation of ABCA1 protein expression and function in hepatic and pancreatic islet cells by miR-145","volume":"33","author":"Kang","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2021.101109_bb0875","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.301","article-title":"Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRalpha expression and cholesterol homeostasis","volume":"4","author":"Adlakha","year":"2013","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb0880","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.expneurol.2011.11.010","article-title":"MiR-106b impairs cholesterol efflux and increases Abeta levels by repressing ABCA1 expression","volume":"235","author":"Kim","year":"2012","journal-title":"Exp Neurol"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb0885","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm.3949","article-title":"MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels","volume":"21","author":"Goedeke","year":"2015","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb0890","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1161\/ATVBAHA.116.308472","article-title":"Pim-1L protects cell surface-resident ABCA1 from lysosomal degradation in hepatocytes and thereby regulates plasma high-density lipoprotein level","volume":"36","author":"Katsube","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5497","key":"10.1016\/j.plipres.2021.101109_bb0895","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1126\/science.290.5497.1771","article-title":"Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters","volume":"290","author":"Berge","year":"2000","journal-title":"Science (New York, NY)"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb0900","doi-asserted-by":"crossref","first-page":"7308","DOI":"10.1074\/jbc.M110.210880","article-title":"Sequences in the nonconsensus nucleotide-binding domain of ABCG5\/ABCG8 required for sterol transport","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"issue":"7604","key":"10.1016\/j.plipres.2021.101109_bb0905","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature17666","article-title":"Crystal structure of the human sterol transporter ABCG5\/ABCG8","volume":"533","author":"Lee","year":"2016","journal-title":"Nature"},{"issue":"32","key":"10.1016\/j.plipres.2021.101109_bb0910","doi-asserted-by":"crossref","first-page":"9929","DOI":"10.1021\/bi0608055","article-title":"Purification and ATP hydrolysis of the putative cholesterol transporters ABCG5 and ABCG8","volume":"45","author":"Wang","year":"2006","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0915","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/iub.1165","article-title":"ATP-binding cassette transporters and cholesterol translocation","volume":"65","author":"Li","year":"2013","journal-title":"IUBMB Life"},{"issue":"48","key":"10.1016\/j.plipres.2021.101109_bb0920","doi-asserted-by":"crossref","first-page":"48275","DOI":"10.1074\/jbc.M310223200","article-title":"ABCG5 and ABCG8 are obligate heterodimers for protein trafficking and biliary cholesterol excretion","volume":"278","author":"Graf","year":"2003","journal-title":"J Biol Chem"},{"issue":"47","key":"10.1016\/j.plipres.2021.101109_bb0925","first-page":"5936","article-title":"Biliary cholesterol secretion: more than a simple ABC","volume":"16","author":"Dikkers","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.plipres.2021.101109_bb0930","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cca.2013.11.010","article-title":"ABCG5\/ABCG8 in cholesterol excretion and atherosclerosis","volume":"428","author":"Yu","year":"2014","journal-title":"Clin Chim Acta; Int J Clin Chem"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0935","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1172\/JCI0216000","article-title":"Coexpression of ATP-binding cassette proteins ABCG5 and ABCG8 permits their transport to the apical surface","volume":"110","author":"Graf","year":"2002","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb0940","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1194\/jlr.M053454","article-title":"The combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination","volume":"56","author":"Wang","year":"2015","journal-title":"J Lipid Res"},{"issue":"25","key":"10.1016\/j.plipres.2021.101109_bb0945","doi-asserted-by":"crossref","first-page":"16237","DOI":"10.1073\/pnas.252582399","article-title":"Disruption of Abcg5 and Abcg8 in mice reveals their crucial role in biliary cholesterol secretion","volume":"99","author":"Yu","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2021.101109_bb0950","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1741-7015-2-5","article-title":"A mouse model of sitosterolemia: absence of Abcg8\/sterolin-2 results in failure to secrete biliary cholesterol","volume":"2","author":"Klett","year":"2004","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb0955","doi-asserted-by":"crossref","first-page":"G414","DOI":"10.1152\/ajpgi.00557.2005","article-title":"Abcg5\/Abcg8-independent pathways contribute to hepatobiliary cholesterol secretion in mice","volume":"291","author":"Plosch","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb0960","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0168-8278(03)00093-X","article-title":"Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice","volume":"38","author":"Kosters","year":"2003","journal-title":"J Hepatol"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb0965","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1074\/jbc.M411080200","article-title":"Expression of ABCG5 and ABCG8 is required for regulation of biliary cholesterol secretion","volume":"280","author":"Yu","year":"2005","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.plipres.2021.101109_bb0970","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1016\/j.febslet.2007.08.052","article-title":"The sterol transporting heterodimer ABCG5\/ABCG8 requires bile salts to mediate cholesterol efflux","volume":"581","author":"Vrins","year":"2007","journal-title":"FEBS Lett"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb0975","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1194\/jlr.M500115-JLR200","article-title":"ABCG5 and ABCG8 require MDR2 for secretion of cholesterol into bile","volume":"46","author":"Langheim","year":"2005","journal-title":"J Lipid Res"},{"issue":"18","key":"10.1016\/j.plipres.2021.101109_bb0980","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1021\/bi800292v","article-title":"Purification and reconstitution of sterol transfer by native mouse ABCG5 and ABCG8","volume":"47","author":"Wang","year":"2008","journal-title":"Biochemistry"},{"issue":"34","key":"10.1016\/j.plipres.2021.101109_bb0985","doi-asserted-by":"crossref","first-page":"28564","DOI":"10.1074\/jbc.M112.360081","article-title":"The ABCG5 ABCG8 sterol transporter opposes the development of fatty liver disease and loss of glycemic control independently of phytosterol accumulation","volume":"287","author":"Su","year":"2012","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb0990","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/ATVBAHA.113.302355","article-title":"Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db\/db mice","volume":"34","author":"Su","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb0995","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s00125-006-0177-8","article-title":"Messenger RNA levels of genes involved in dysregulation of postprandial lipoproteins in type 2 diabetes: the role of Niemann-Pick C1-like 1, ATP-binding cassette, transporters G5 and G8, and of microsomal triglyceride transfer protein","volume":"49","author":"Lally","year":"2006","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1000","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00125-003-1261-y","article-title":"Down-regulation of hepatic and intestinal Abcg5 and Abcg8 expression associated with altered sterol fluxes in rats with streptozotocin-induced diabetes","volume":"47","author":"Bloks","year":"2004","journal-title":"Diabetologia"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb1005","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1253\/circj.CJ-19-0317","article-title":"Rare and deleterious mutations in ABCG5\/ABCG8 genes contribute to mimicking and worsening of familial hypercholesterolemia phenotype","volume":"83","author":"Tada","year":"2019","journal-title":"Circul J: Off J Jpn Circul Soc"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/humu.9047","article-title":"Mutations in the human ATP-binding cassette transporters ABCG5 and ABCG8 in sitosterolemia","volume":"20","author":"Heimerl","year":"2002","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1015","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2010.01.010","article-title":"Genetic variations at ABCG5\/G8 genes modulate plasma lipids concentrations in patients with familial hypercholesterolemia","volume":"210","author":"Garcia-Rios","year":"2010","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb1020","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1194\/jlr.M400167-JLR200","article-title":"High-level expression of ABCG5 and ABCG8 attenuates diet-induced hypercholesterolemia and atherosclerosis in Ldlr-\/- mice","volume":"45","author":"Wilund","year":"2004","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1194\/jlr.M054544","article-title":"Relative roles of ABCG5\/ABCG8 in liver and intestine","volume":"56","author":"Wang","year":"2015","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1030","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1172\/JCI0216001","article-title":"Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol","volume":"110","author":"Yu","year":"2002","journal-title":"J Clin Invest"},{"issue":"22","key":"10.1016\/j.plipres.2021.101109_bb1035","doi-asserted-by":"crossref","first-page":"22913","DOI":"10.1074\/jbc.M402838200","article-title":"Hepatic ABCG5 and ABCG8 overexpression increases hepatobiliary sterol transport but does not alter aortic atherosclerosis in transgenic mice","volume":"279","author":"Wu","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1194\/jlr.M600353-JLR200","article-title":"Hepatic ABCG5\/G8 overexpression reduces apoB-lipoproteins and atherosclerosis when cholesterol absorption is inhibited","volume":"48","author":"Basso","year":"2007","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb1045","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbalip.2019.04.010","article-title":"Diosgenin regulates cholesterol metabolism in hypercholesterolemic rats by inhibiting NPC1L1 and enhancing ABCG5 and ABCG8","volume":"1864","author":"Li","year":"2019","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb1050","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1194\/jlr.M700470-JLR200","article-title":"Liver X receptor-mediated activation of reverse cholesterol transport from macrophages to feces in vivo requires ABCG5\/G8","volume":"49","author":"Calpe-Berdiel","year":"2008","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1055","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.atherosclerosis.2015.10.010","article-title":"Hepatic ABCG5\/G8 overexpression substantially increases biliary cholesterol secretion but does not impact in vivo macrophage-to-feces RCT","volume":"243","author":"Dikkers","year":"2015","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1060","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.metabol.2014.06.014","article-title":"Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment","volume":"63","author":"Altemus","year":"2014","journal-title":"Metab Clin Exp"},{"issue":"21","key":"10.1016\/j.plipres.2021.101109_bb1065","doi-asserted-by":"crossref","first-page":"18793","DOI":"10.1074\/jbc.M109927200","article-title":"Regulation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 by the liver X receptors alpha and beta","volume":"277","author":"Repa","year":"2002","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1070","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5483\/BMBRep.2013.46.6.246","article-title":"Cooperative transcriptional activation of ATP-binding cassette sterol transporters ABCG5 and ABCG8 genes by nuclear receptors including Liver-X-Receptor","volume":"46","author":"Back","year":"2013","journal-title":"BMB Rep"},{"issue":"7611","key":"10.1016\/j.plipres.2021.101109_bb1075","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/nature18628","article-title":"TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis","volume":"535","author":"Hsieh","year":"2016","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1080","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.25861","article-title":"Stimulation of murine biliary cholesterol secretion by thyroid hormone is dependent on a functional ABCG5\/G8 complex","volume":"56","author":"Bonde","year":"2012","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1085","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1194\/jlr.M500441-JLR200","article-title":"Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice","volume":"47","author":"Wang","year":"2006","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb1090","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1194\/jlr.C400002-JLR200","article-title":"The orphan nuclear receptor LRH-1 activates the ABCG5\/ABCG8 intergenic promoter","volume":"45","author":"Freeman","year":"2004","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb1095","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1128\/MCB.01894-06","article-title":"Cooperative interaction between hepatocyte nuclear factor 4 alpha and GATA transcription factors regulates ATP-binding cassette sterol transporters ABCG5 and ABCG8","volume":"27","author":"Sumi","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb1100","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nm1785","article-title":"Hepatic insulin resistance directly promotes formation of cholesterol gallstones","volume":"14","author":"Biddinger","year":"2008","journal-title":"Nat Med"},{"issue":"18","key":"10.1016\/j.plipres.2021.101109_bb1105","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1128\/MCB.24.18.7931-7940.2004","article-title":"Nuclear receptors CAR and PXR cross talk with FOXO1 to regulate genes that encode drug-metabolizing and gluconeogenic enzymes","volume":"24","author":"Kodama","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"31","key":"10.1016\/j.plipres.2021.101109_bb1110","doi-asserted-by":"crossref","first-page":"22397","DOI":"10.1074\/jbc.M702236200","article-title":"Defects in the leptin axis reduce abundance of the ABCG5-ABCG8 sterol transporter in liver","volume":"282","author":"Sabeva","year":"2007","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1115","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.metabol.2015.08.005","article-title":"GRP78 rescues the ABCG5 ABCG8 sterol transporter in db\/db mice","volume":"64","author":"Wang","year":"2015","journal-title":"Metab Clin Exp"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1120","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbrc.2006.06.032","article-title":"Calreticulin facilitates the cell surface expression of ABCG5\/G8","volume":"347","author":"Okiyoneda","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2021.101109_bb1125","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1038\/srep04258","article-title":"Inhibition of post-translational N-glycosylation by HRD1 that controls the fate of ABCG5\/8 transporter","volume":"4","author":"Suzuki","year":"2014","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1130","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/hep.24107","article-title":"Overexpression of cholesterol 7alpha-hydroxylase promotes hepatic bile acid synthesis and secretion and maintains cholesterol homeostasis","volume":"53","author":"Li","year":"2011","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1135","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1194\/jlr.R900010-JLR200","article-title":"Bile acids: regulation of synthesis","volume":"50","author":"Chiang","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2021.101109_bb1140","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mam.2017.03.003","article-title":"Bile acid analysis in human disorders of bile acid biosynthesis","volume":"56","author":"Vaz","year":"2017","journal-title":"Mol Asp Med"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb1145","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1194\/jlr.M050765","article-title":"Structural characterization of human cholesterol 7alpha-hydroxylase","volume":"55","author":"Tempel","year":"2014","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1150","doi-asserted-by":"crossref","first-page":"G221","DOI":"10.1152\/ajpgi.00322.2012","article-title":"Hepatic overexpression of Abcb11 in mice promotes the conservation of bile acids within the enterohepatic circulation","volume":"304","author":"Henkel","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1160","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hep4.1129","article-title":"Deficiency of cholesterol 7alpha-hydroxylase in bile acid synthesis exacerbates alcohol-induced liver injury in mice","volume":"2","author":"Donepudi","year":"2018","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1165","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.23721","article-title":"Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice","volume":"52","author":"Li","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1170","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1194\/jlr.M069807","article-title":"Cholesterol 7alpha-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis","volume":"57","author":"Liu","year":"2016","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1175","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.bcp.2012.08.029","article-title":"Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease","volume":"84","author":"Kim","year":"2012","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1180","doi-asserted-by":"crossref","first-page":"6866","DOI":"10.3390\/md13116866","article-title":"Polyphenol-rich fraction of ecklonia cava improves nonalcoholic fatty liver disease in high fat diet-fed mice","volume":"13","author":"Park","year":"2015","journal-title":"Marine Drugs"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1185","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1074\/jbc.M111.305789","article-title":"Glucose and insulin induction of bile acid synthesis: mechanisms and implication in diabetes and obesity","volume":"287","author":"Li","year":"2012","journal-title":"J Biol Chem"},{"issue":"1-2","key":"10.1016\/j.plipres.2021.101109_bb1190","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mce.2011.06.028","article-title":"High expression of liver histone deacetylase 3 contributes to high-fat-diet-induced metabolic syndrome by suppressing the PPAR-\u03b3 and LXR-\u03b1-pathways in E3 rats","volume":"344","author":"Li","year":"2011","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1195","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/hq0102.102588","article-title":"Transgenic expression of cholesterol-7-alpha-hydroxylase prevents atherosclerosis in C57BL\/6J mice","volume":"22","author":"Miyake","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1200","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20040339","article-title":"Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical events","volume":"108","author":"Hofman","year":"2005","journal-title":"Clin Sci (Lond, Engl: 1979)"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb1205","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1039\/C8FO02585A","article-title":"Soybean germ oil reduces blood cholesterol by inhibiting cholesterol absorption and enhancing bile acid excretion","volume":"10","author":"Zhu","year":"2019","journal-title":"Food Funct"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1210","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s11130-014-0405-1","article-title":"Mung bean decreases plasma cholesterol by up-regulation of CYP7A1","volume":"69","author":"Yao","year":"2014","journal-title":"Plant Foods Human Nutrition (Dordrecht, Netherlands)"},{"key":"10.1016\/j.plipres.2021.101109_bb1215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1476-511X-11-56","article-title":"Dietary resveratrol increases the expression of hepatic 7alpha-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL\/6J mice","volume":"11","author":"Chen","year":"2012","journal-title":"Lipids Health Dis"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb1220","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/mnfr.201100659","article-title":"Cyanidin-3-O-beta-glucoside upregulates hepatic cholesterol 7alpha-hydroxylase expression and reduces hypercholesterolemia in mice","volume":"56","author":"Wang","year":"2012","journal-title":"Mol Nutr Food Res"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1225","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jnutbio.2009.10.007","article-title":"Hypocholesterolemic activity of grape seed proanthocyanidin is mediated by enhancement of bile acid excretion and up-regulation of CYP7A1","volume":"21","author":"Jiao","year":"2010","journal-title":"J Nutr Biochem"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1230","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4162\/nrp.2007.1.3.175","article-title":"Dietary chitosan enhances hepatic CYP7A1 activity and reduces plasma and liver cholesterol concentrations in diet-induced hypercholesterolemia in rats","volume":"1","author":"Moon","year":"2007","journal-title":"Nutr Res Pract"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1235","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1194\/jlr.M200489-JLR200","article-title":"Hypercholesterolemia and changes in lipid and bile acid metabolism in male and female cyp7A1-deficient mice","volume":"44","author":"Erickson","year":"2003","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1240","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1097-2765(00)00051-4","article-title":"A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis","volume":"6","author":"Goodwin","year":"2000","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1245","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.22627","article-title":"Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression","volume":"49","author":"Song","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb1250","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1194\/jlr.M005546","article-title":"Retinoic acid represses CYP7A1 expression in human hepatocytes and HepG2 cells by FXR\/RXR-dependent and independent mechanisms","volume":"51","author":"Cai","year":"2010","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb1255","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/j.gastro.2013.12.027","article-title":"Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol","volume":"146","author":"Chow","year":"2014","journal-title":"Gastroenterology"},{"issue":"5266","key":"10.1016\/j.plipres.2021.101109_bb1260","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.272.5266.1336","article-title":"An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors","volume":"272","author":"Seol","year":"1996","journal-title":"Science (New York, NY)"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1265","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1042\/BJ20141494","article-title":"Orphan nuclear receptor oestrogen-related receptor gamma (ERRgamma) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression","volume":"470","author":"Zhang","year":"2015","journal-title":"Biochem J"},{"key":"10.1016\/j.plipres.2021.101109_bb1270","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bcp.2019.04.008","article-title":"Advances in understanding the regulatory mechanism of cholesterol 7alpha-hydroxylase","volume":"164","author":"Ge","year":"2019","journal-title":"Biochem Pharmacol"},{"issue":"50","key":"10.1016\/j.plipres.2021.101109_bb1275","doi-asserted-by":"crossref","first-page":"50047","DOI":"10.1074\/jbc.M309736200","article-title":"PGC-1alpha activates CYP7A1 and bile acid biosynthesis","volume":"278","author":"Shin","year":"2003","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1280","doi-asserted-by":"crossref","first-page":"G74","DOI":"10.1152\/ajpgi.00258.2004","article-title":"Mechanism of rifampicin and pregnane X receptor inhibition of human cholesterol 7 alpha-hydroxylase gene transcription","volume":"288","author":"Li","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"43","key":"10.1016\/j.plipres.2021.101109_bb1285","doi-asserted-by":"crossref","first-page":"45139","DOI":"10.1074\/jbc.M405423200","article-title":"Ligand-activated pregnane X receptor interferes with HNF-4 signaling by targeting a common coactivator PGC-1alpha. Functional implications in hepatic cholesterol and glucose metabolism","volume":"279","author":"Bhalla","year":"2004","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1290","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1128\/MCB.20.1.187-195.2000","article-title":"The orphan nuclear receptor SHP inhibits hepatocyte nuclear factor 4 and retinoid X receptor transactivation: two mechanisms for repression","volume":"20","author":"Lee","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1295","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1210\/me.2007-0196","article-title":"Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-gamma coactivator 1alpha in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c","volume":"21","author":"Ponugoti","year":"2007","journal-title":"Mol Endocrinol (Baltimore, Md)"},{"issue":"1\u20132","key":"10.1016\/j.plipres.2021.101109_bb1300","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0378-1119(00)00518-7","article-title":"Regulation of cholesterol 7alpha-hydroxylase gene (CYP7A1) transcription by the liver orphan receptor (LXRalpha)","volume":"262","author":"Chiang","year":"2001","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1305","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1194\/jlr.M500449-JLR200","article-title":"The stimulatory effect of LXRalpha is blocked by SHP despite the presence of a LXRalpha binding site in the rabbit CYP7A1 promoter","volume":"47","author":"Shang","year":"2006","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1310","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hep.23289","article-title":"Mechanisms for increased expression of cholesterol 7alpha-hydroxylase (Cyp7a1) in lactating rats","volume":"51","author":"Wooton-Kee","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1315","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1210\/me.2002-0246","article-title":"Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha","volume":"17","author":"Goodwin","year":"2003","journal-title":"Mol Endocrinol (Baltimore, Md)"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.plipres.2021.101109_bb1325","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3389\/fphys.2018.00645","article-title":"Prenatal exposure to a maternal high fat diet increases hepatic cholesterol accumulation in intrauterine growth restricted rats in part through MicroRNA-122 inhibition of Cyp7a1","volume":"9","author":"Zinkhan","year":"2018","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb1330","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1194\/jlr.M004531","article-title":"A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes","volume":"51","author":"Song","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2021.101109_bb1335","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11658-018-0083-3","article-title":"MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1","volume":"23","author":"Gong","year":"2018","journal-title":"Cell Mol Biol Lett"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb1340","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1074\/jbc.M109.085431","article-title":"MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle","volume":"285","author":"Takagi","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2021.101109_bb1345","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat Commun"},{"issue":"6643","key":"10.1016\/j.plipres.2021.101109_bb1350","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/41672","article-title":"LDL-receptor structure. Calcium cages, acid baths and recycling receptors","volume":"388","author":"Brown","year":"1997","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1355","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7150\/ijbs.14027","article-title":"Dysregulation of the low-density lipoprotein receptor pathway is involved in lipid disorder-mediated organ injury","volume":"12","author":"Zhang","year":"2016","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1360","first-page":"19","article-title":"Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis","volume":"85","author":"Go","year":"2012","journal-title":"Yale J Biol Med"},{"issue":"49","key":"10.1016\/j.plipres.2021.101109_bb1365","doi-asserted-by":"crossref","first-page":"40996","DOI":"10.1074\/jbc.M509394200","article-title":"The modular adaptor protein autosomal recessive hypercholesterolemia (ARH) promotes low density lipoprotein receptor clustering into clathrin-coated pits","volume":"280","author":"Garuti","year":"2005","journal-title":"J Biol Chem"},{"issue":"Pt 20","key":"10.1016\/j.plipres.2021.101109_bb1370","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1242\/jcs.03217","article-title":"The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH","volume":"119","author":"Maurer","year":"2006","journal-title":"J Cell Sci"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1375","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1194\/jlr.M063065","article-title":"Endocytic adaptors Arh and Dab2 control homeostasis of circulatory cholesterol","volume":"57","author":"Tao","year":"2016","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb1380","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/01.RES.0000146946.78540.46","article-title":"Disruption of autosomal recessive hypercholesterolemia gene shows different phenotype in vitro and in vivo","volume":"95","author":"Harada-Shiba","year":"2004","journal-title":"Circ Res"},{"issue":"5602","key":"10.1016\/j.plipres.2021.101109_bb1385","doi-asserted-by":"crossref","DOI":"10.1126\/science.1078124","article-title":"Structure of the LDL receptor extracellular domain at endosomal pH","volume":"298","author":"Rudenko","year":"2002","journal-title":"Science (New York, NY)"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb1390","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1161\/CIRCRESAHA.117.312004","article-title":"The COMMD family regulates plasma LDL levels and attenuates atherosclerosis through stabilizing the CCC complex in endosomal LDLR trafficking","volume":"122","author":"Fedoseienko","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.plipres.2021.101109_bb1395","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1038\/ncomms10961","article-title":"CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL","volume":"7","author":"Bartuzi","year":"2016","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1400","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126462","article-title":"The hepatic WASH complex is required for efficient plasma LDL and HDL cholesterol clearance","volume":"4","author":"Wijers","year":"2019","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1405","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/ncb3610","article-title":"Retriever is a multiprotein complex for retromer-independent endosomal cargo recycling","volume":"19","author":"McNally","year":"2017","journal-title":"Nat Cell Biol"},{"issue":"16","key":"10.1016\/j.plipres.2021.101109_bb1410","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1093\/emboj\/cdf435","article-title":"The PX-domain protein SNX17 interacts with members of the LDL receptor family and modulates endocytosis of the LDL receptor","volume":"21","author":"Stockinger","year":"2002","journal-title":"EMBO J"},{"issue":"Pt 17","key":"10.1016\/j.plipres.2021.101109_bb1415","first-page":"3961","article-title":"NDRG1 functions in LDL receptor trafficking by regulating endosomal recycling and degradation","volume":"126","author":"Pietiainen","year":"2013","journal-title":"J Cell Sci"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1420","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0022-2275(20)41629-3","article-title":"Discrete subspecies of human low density lipoproteins are heterogeneous in their interaction with the cellular LDL receptor","volume":"32","author":"Nigon","year":"1991","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2021.101109_bb1425","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.plipres.2018.12.002","article-title":"Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis","volume":"73","author":"Yu","year":"2019","journal-title":"Prog Lipid Res"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1430","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1440-1746.2010.06560.x","article-title":"Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis","volume":"26","author":"Zhao","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb1435","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.86442","article-title":"Atherogenesis and metabolic dysregulation in LDL receptor-knockout rats","volume":"2","author":"Sithu","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.plipres.2021.101109_bb1440","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3389\/fphar.2017.00372","article-title":"Statins and new-onset diabetes mellitus: LDL receptor may provide a key link","volume":"8","author":"Yu","year":"2017","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1445","first-page":"78","article-title":"LEP, LDLR and APOA4 gene polymorphisms and their relationship with the risk of overweight, obesity and chronic diseases in adults of the State of Sucre","volume":"36","author":"Rodr\u00edguez-Arroyo","year":"2016","journal-title":"Venezuela, Biomed"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1450","doi-asserted-by":"crossref","first-page":"793","DOI":"10.14740\/jocmr2739w","article-title":"LDLR C1725T gene polymorphism frequency in type 2 diabetes mellitus patients with dyslipidemia","volume":"8","author":"Eroglu","year":"2016","journal-title":"J Clin Med Res"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1455","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1002\/hep.23941","article-title":"Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice","volume":"52","author":"Gupte","year":"2010","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S002966511500244X","article-title":"Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-\/- mice","volume":"75","author":"Jump","year":"2016","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030668","article-title":"LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease","volume":"7","author":"Bieghs","year":"2012","journal-title":"PLoS One"},{"issue":"1-2","key":"10.1016\/j.plipres.2021.101109_bb1470","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11010-010-0498-2","article-title":"Differential response of two models of genetically modified mice fed with high fat and cholesterol diets: relationship to the study of non-alcoholic steatohepatitis","volume":"343","author":"Rodriguez-Sanabria","year":"2010","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1475","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1152\/ajpendo.2002.282.1.E207","article-title":"LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice","volume":"282","author":"Schreyer","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"17","key":"10.1016\/j.plipres.2021.101109_bb1480","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1111\/j.1742-4658.2011.08238.x","article-title":"Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice","volume":"278","author":"Karavia","year":"2011","journal-title":"FEBS J"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1485","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.ATV.0000149146.32385.1b","article-title":"Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4","volume":"25","author":"Seidelmann","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.plipres.2021.101109_bb1490","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biocel.2015.01.011","article-title":"Activation of mTORC1 disrupted LDL receptor pathway: a potential new mechanism for the progression of non-alcoholic fatty liver disease","volume":"61","author":"Liu","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1495","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0021-9150(00)00414-7","article-title":"Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice","volume":"153","author":"Murayama","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.plipres.2021.101109_bb1500","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.atherosclerosis.2017.06.014","article-title":"Analysis of LDLR variants from homozygous FH patients carrying multiple mutations in the LDLR gene","volume":"263","author":"Jiang","year":"2017","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1505","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/eurheartj\/ehl366","article-title":"Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia","volume":"28","author":"Souverein","year":"2007","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1510","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1172\/JCI116663","article-title":"Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery","volume":"92","author":"Ishibashi","year":"1993","journal-title":"J Clin Investig"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb1515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035835","article-title":"Hyperlipidemia and atherosclerotic lesion development in Ldlr-deficient mice on a long-term high-fat diet","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.plipres.2021.101109_bb1520","first-page":"1845","article-title":"Experimental models of murine atherosclerosis: does perception match reality?","volume":"114","author":"Johnston","year":"2018","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1525","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1074\/jbc.270.3.1161","article-title":"Cooperation by sterol regulatory element-binding protein and Sp1 in sterol regulation of low density lipoprotein receptor gene","volume":"270","author":"Sanchez","year":"1995","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1530","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1074\/jbc.M509417200","article-title":"A novel functional interaction between the Sp1-like protein KLF13 and SREBP-Sp1 activation complex underlies regulation of low density lipoprotein receptor promoter function","volume":"281","author":"Natesampillai","year":"2006","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1535","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139799","article-title":"Piperine induces hepatic low-density lipoprotein receptor expression through proteolytic activation of sterol regulatory element-binding proteins","volume":"10","author":"Ochiai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.plipres.2021.101109_bb1540","doi-asserted-by":"crossref","first-page":"31120","DOI":"10.3402\/fnr.v60.31120","article-title":"Genistein upregulates LDLR levels via JNK-mediated activation of SREBP-2","volume":"60","author":"Kartawijaya","year":"2016","journal-title":"Food Nutr Res"},{"key":"10.1016\/j.plipres.2021.101109_bb1545","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12906-016-1165-2","article-title":"Role of hesperetin in LDL-receptor expression in hepatoma HepG2 cells","volume":"16","author":"Bawazeer","year":"2016","journal-title":"BMC Complement Altern Med"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1550","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.jnutbio.2015.07.009","article-title":"Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression","volume":"26","author":"Yang","year":"2015","journal-title":"J Nutr Biochem"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1555","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2011.11.006","article-title":"Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins","volume":"220","author":"Yashiro","year":"2012","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb1560","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1074\/jbc.275.7.5214","article-title":"Identification of a novel sterol-independent regulatory element in the human low density lipoprotein receptor promoter","volume":"275","author":"Liu","year":"2000","journal-title":"J Biol Chem"},{"issue":"45","key":"10.1016\/j.plipres.2021.101109_bb1565","doi-asserted-by":"crossref","first-page":"44246","DOI":"10.1074\/jbc.M305564200","article-title":"Specific interaction of Egr1 and c\/EBPbeta leads to the transcriptional activation of the human low density lipoprotein receptor gene","volume":"278","author":"Zhang","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1570","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1194\/jlr.M400425-JLR200","article-title":"In vivo activities of cytokine oncostatin M in the regulation of plasma lipid levels","volume":"46","author":"Kong","year":"2005","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb1575","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1194\/jlr.M200126-JLR200","article-title":"Identification of Egr1 as the oncostatin M-induced transcription activator that binds to sterol-independent regulatory element of human LDL receptor promoter","volume":"43","author":"Zhang","year":"2002","journal-title":"J Lipid Res"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1580","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/BJ20150666","article-title":"A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARdelta activation","volume":"472","author":"Shende","year":"2015","journal-title":"Biochem J"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1585","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(84)90188-0","article-title":"The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA","volume":"39","author":"Yamamoto","year":"1984","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.plipres.2021.101109_bb1590","doi-asserted-by":"crossref","first-page":"10037","DOI":"10.1093\/nar\/gku652","article-title":"ZFP36L1 and ZFP36L2 control LDLR mRNA stability via the ERK-RSK pathway","volume":"42","author":"Adachi","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1595","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1194\/jlr.M800375-JLR200","article-title":"Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements","volume":"50","author":"Li","year":"2009","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1600","doi-asserted-by":"crossref","first-page":"16174","DOI":"10.1038\/s41598-018-34237-6","article-title":"Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA","volume":"8","author":"Bjune","year":"2018","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb1605","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1194\/jlr.M049429","article-title":"A novel posttranscriptional mechanism for dietary cholesterol-mediated suppression of liver LDL receptor expression","volume":"55","author":"Singh","year":"2014","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1610","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/ATVBAHA.118.311122","article-title":"Farnesoid X receptor activation by obeticholic acid elevates liver low-density lipoprotein receptor expression by mRNA stabilization and reduces plasma low-density lipoprotein cholesterol in mice","volume":"38","author":"Singh","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1615","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.atherosclerosis.2012.09.033","article-title":"5-Aminoimidazole-4-carboxamide ribonucleoside stabilizes low density lipoprotein receptor mRNA in hepatocytes via ERK-dependent HuR binding to an AU-rich element","volume":"226","author":"Yashiro","year":"2013","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1620","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/ATVBAHA.112.301131","article-title":"The critical role of mRNA destabilizing protein heterogeneous nuclear ribonucleoprotein d in 3' untranslated region-mediated decay of low-density lipoprotein receptor mRNA in liver tissue","volume":"34","author":"Singh","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1625","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.atherosclerosis.2015.10.026","article-title":"microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator","volume":"243","author":"Jiang","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1630","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.atherosclerosis.2015.08.023","article-title":"MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis","volume":"242","author":"Alvarez","year":"2015","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1635","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.3980","article-title":"Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis","volume":"21","author":"Wagschal","year":"2015","journal-title":"Nat Med"},{"issue":"10106","key":"10.1016\/j.plipres.2021.101109_bb1640","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(17)32290-0","article-title":"Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial","volume":"390","author":"Giugliano","year":"2017","journal-title":"Lancet (Lond, Engl)"},{"issue":"18","key":"10.1016\/j.plipres.2021.101109_bb1645","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"New Engl J Med"},{"issue":"20","key":"10.1016\/j.plipres.2021.101109_bb1650","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/eurheartj\/ehx002","article-title":"PCSK9 monoclonal antibodies reverse the pro-inflammatory profile of monocytes in familial hypercholesterolaemia","volume":"38","author":"Bernelot Moens","year":"2017","journal-title":"Eur Heart J"},{"issue":"16","key":"10.1016\/j.plipres.2021.101109_bb1655","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"New Engl J Med"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1660","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.tibs.2006.12.008","article-title":"Molecular biology of PCSK9: its role in LDL metabolism","volume":"32","author":"Horton","year":"2007","journal-title":"Trends Biochem Sci"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1665","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1073\/pnas.0409736102","article-title":"Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment","volume":"102","author":"Maxwell","year":"2005","journal-title":"Proceed Nat Acad Sci USA"},{"issue":"42","key":"10.1016\/j.plipres.2021.101109_bb1670","doi-asserted-by":"crossref","first-page":"28856","DOI":"10.1074\/jbc.M109.037085","article-title":"Dissection of the endogenous cellular pathways of PCSK9-induced low density lipoprotein receptor degradation: evidence for an intracellular route","volume":"284","author":"Poirier","year":"2009","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1675","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1073\/pnas.0712064105","article-title":"Molecular basis for LDL receptor recognition by PCSK9","volume":"105","author":"Kwon","year":"2008","journal-title":"Proceed Nat Acad Sci USA"},{"issue":"25","key":"10.1016\/j.plipres.2021.101109_bb1680","doi-asserted-by":"crossref","first-page":"18602","DOI":"10.1074\/jbc.M702027200","article-title":"Binding of proprotein convertase subtilisin\/kexin type 9 to epidermal growth factor-like repeat A of low density lipoprotein receptor decreases receptor recycling and increases degradation","volume":"282","author":"Zhang","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1685","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41467-017-00568-7","article-title":"Heparan sulfate proteoglycans present PCSK9 to the LDL receptor","volume":"8","author":"Gustafsen","year":"2017","journal-title":"Nat Commun"},{"issue":"28","key":"10.1016\/j.plipres.2021.101109_bb1690","doi-asserted-by":"crossref","first-page":"20502","DOI":"10.1074\/jbc.M701634200","article-title":"Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation","volume":"282","author":"Fisher","year":"2007","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1695","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nsmb1235","article-title":"Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia","volume":"14","author":"Cunningham","year":"2007","journal-title":"Nat Struct Mol Biol"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb1700","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI29383","article-title":"Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice","volume":"116","author":"Lagace","year":"2006","journal-title":"J Clin Investig"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1705","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ymgme.2010.05.003","article-title":"Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domain","volume":"101","author":"Strom","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb1710","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1172\/JCI45504","article-title":"The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans","volume":"121","author":"Weissglas-Volkov","year":"2011","journal-title":"J Clin Investig"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb1715","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/ATVBAHA.119.312589","article-title":"IDOL G51S variant is associated with high blood cholesterol and increases low-density lipoprotein receptor degradation","volume":"39","author":"Adi","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5936","key":"10.1016\/j.plipres.2021.101109_bb1720","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1168974","article-title":"LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor","volume":"325","author":"Zelcer","year":"2009","journal-title":"Science (New York, NY)"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1725","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cmet.2014.10.001","article-title":"The LXR-Idol axis differentially regulates plasma LDL levels in primates and mice","volume":"20","author":"Hong","year":"2014","journal-title":"Cell Metab"},{"issue":"50","key":"10.1016\/j.plipres.2021.101109_bb1730","doi-asserted-by":"crossref","first-page":"20107","DOI":"10.1073\/pnas.1111589108","article-title":"FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors","volume":"108","author":"Calkin","year":"2011","journal-title":"Proceed Nat Acad Sci USA"},{"issue":"34","key":"10.1016\/j.plipres.2021.101109_bb1735","doi-asserted-by":"crossref","first-page":"30190","DOI":"10.1074\/jbc.M111.249557","article-title":"Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL)","volume":"286","author":"Sorrentino","year":"2011","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb1740","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1101\/gad.2056211","article-title":"The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor","volume":"25","author":"Zhang","year":"2011","journal-title":"Genes Dev"},{"issue":"7237","key":"10.1016\/j.plipres.2021.101109_bb1745","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature07961","article-title":"The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins","volume":"458","author":"Raiborg","year":"2009","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb1750","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1194\/jlr.M037713","article-title":"The LXR-IDOL axis defines a clathrin-, caveolae-, and dynamin-independent endocytic route for LDLR internalization and lysosomal degradation","volume":"54","author":"Sorrentino","year":"2013","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb1755","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1128\/MCB.01716-12","article-title":"IDOL stimulates clathrin-independent endocytosis and multivesicular body-mediated lysosomal degradation of the low-density lipoprotein receptor","volume":"33","author":"Scotti","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1760","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/ATVBAHA.113.302670","article-title":"Hepatic overexpression of idol increases circulating protein convertase subtilisin\/kexin type 9 in mice and hamsters via dual mechanisms: sterol regulatory element-binding protein 2 and low-density lipoprotein receptor-dependent pathways","volume":"34","author":"Sasaki","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb1765","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1128\/MCB.01469-10","article-title":"Targeted disruption of the idol gene alters cellular regulation of the low-density lipoprotein receptor by sterols and liver x receptor agonists","volume":"31","author":"Scotti","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"47","key":"10.1016\/j.plipres.2021.101109_bb1770","doi-asserted-by":"crossref","first-page":"36596","DOI":"10.1074\/jbc.M006924200","article-title":"High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI","volume":"275","author":"Yancey","year":"2000","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1775","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.tem.2017.02.001","article-title":"SR-BI: A multifunctional receptor in cholesterol homeostasis and atherosclerosis","volume":"28","author":"Linton","year":"2017","journal-title":"Trends Endocrinol Metabol: TEM"},{"key":"10.1016\/j.plipres.2021.101109_bb1780","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev.biochem.68.1.523","article-title":"Charting the fate of the \u201cgood cholesterol\u201d: identification and characterization of the high-density lipoprotein receptor SR-BI","volume":"68","author":"Krieger","year":"1999","journal-title":"Annu Rev Biochem"},{"issue":"6631","key":"10.1016\/j.plipres.2021.101109_bb1785","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/387414a0","article-title":"Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels","volume":"387","author":"Kozarsky","year":"1997","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1790","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00418-014-1251-9","article-title":"Differential basolateral-apical distribution of scavenger receptor, class B, type I in cultured cells and the liver","volume":"142","author":"Fruhw\u00fcrth","year":"2014","journal-title":"Histochem Cell Biol"},{"issue":"17","key":"10.1016\/j.plipres.2021.101109_bb1795","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1021\/bi002825r","article-title":"Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI), are localized to the extracellular receptor domain","volume":"40","author":"Connelly","year":"2001","journal-title":"Biochemistry"},{"issue":"41","key":"10.1016\/j.plipres.2021.101109_bb1800","doi-asserted-by":"crossref","first-page":"26338","DOI":"10.1074\/jbc.273.41.26338","article-title":"The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain","volume":"273","author":"Gu","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1805","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.abb.2010.02.011","article-title":"Extracellular hydrophobic regions in scavenger receptor BI play a key role in mediating HDL-cholesterol transport","volume":"496","author":"Papale","year":"2010","journal-title":"Arch Biochem Biophys"},{"issue":"1-2","key":"10.1016\/j.plipres.2021.101109_bb1810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0303-7207(02)00222-8","article-title":"Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation of steroidogenesis","volume":"195","author":"Azhar","year":"2002","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1815","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.tem.2003.10.002","article-title":"SR-BI and cholesterol uptake into steroidogenic cells","volume":"14","author":"Connelly","year":"2003","journal-title":"Trends Endocrinol Metabol: TEM"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1820","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1172\/JCI8087","article-title":"Defective HDL particle uptake in ob\/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake","volume":"105","author":"Silver","year":"2000","journal-title":"J Clin Investig"},{"issue":"16","key":"10.1016\/j.plipres.2021.101109_bb1825","doi-asserted-by":"crossref","first-page":"11193","DOI":"10.1074\/jbc.M510261200","article-title":"SR-BI-mediated high density lipoprotein (HDL) endocytosis leads to HDL resecretion facilitating cholesterol efflux","volume":"281","author":"Pagler","year":"2006","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1830","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1194\/jlr.M500444-JLR200","article-title":"Hepatic SR-BI-mediated cholesteryl ester selective uptake occurs with unaltered efficiency in the absence of cellular energy","volume":"47","author":"Harder","year":"2006","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb1835","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1194\/jlr.M800055-JLR200","article-title":"Scavenger receptor class B type I localizes to a late endosomal compartment","volume":"49","author":"Ahras","year":"2008","journal-title":"J Lipid Res"},{"issue":"5\u20136","key":"10.1016\/j.plipres.2021.101109_bb1840","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1080\/09687680701300410","article-title":"The inhibition of endocytosis affects HDL-lipid uptake mediated by the human scavenger receptor class B type I","volume":"24","author":"Zhang","year":"2007","journal-title":"Mol Membr Biol"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1845","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1194\/jlr.M700355-JLR200","article-title":"Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo","volume":"49","author":"Van Eck","year":"2008","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb1850","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1194\/jlr.M800130-JLR200","article-title":"The hepatic uptake of VLDL in lrp-ldlr-\/-vldlr-\/- mice is regulated by LPL activity and involves proteoglycans and SR-BI","volume":"49","author":"Hu","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.plipres.2021.101109_bb1855","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.fct.2012.10.026","article-title":"Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats","volume":"52","author":"Xin","year":"2013","journal-title":"Food Chem Toxicol: Int J Publ Br Indus Biol Res Assoc"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb1860","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/db09-1482","article-title":"CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice","volume":"59","author":"Jourdan","year":"2010","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1865","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1499-3872(13)60099-5","article-title":"Upregulation of caveolin-1 and SR-B1 in mice with non-alcoholic fatty liver disease","volume":"12","author":"Qiu","year":"2013","journal-title":"Hepatobil Pancreatic Dis Int: HBPD INT"},{"issue":"44","key":"10.1016\/j.plipres.2021.101109_bb1870","doi-asserted-by":"crossref","first-page":"43224","DOI":"10.1074\/jbc.M302645200","article-title":"Leptin induces the hepatic high density lipoprotein receptor scavenger receptor B type I (SR-BI) but not cholesterol 7alpha-hydroxylase (Cyp7a1) in leptin-deficient (ob\/ob) mice","volume":"278","author":"Lund\u00e5sen","year":"2003","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb1875","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1210\/jc.2002-021664","article-title":"Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the framingham study","volume":"88","author":"Osgood","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1880","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/jc.2008-2800","article-title":"Polymorphisms of the scavenger receptor class B member 1 are associated with insulin resistance with evidence of gene by sex interaction","volume":"94","author":"McCarthy","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1885","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/hh0302.104462","article-title":"Loss of SR-BI expression leads to the early onset of occlusive atherosclerotic coronary artery disease, spontaneous myocardial infarctions, severe cardiac dysfunction, and premature death in apolipoprotein E-deficient mice","volume":"90","author":"Braun","year":"2002","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb1890","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1161\/01.ATV.0000083343.19940.A0","article-title":"Scavenger receptor class B type I-mediated protection against atherosclerosis in LDL receptor-negative mice involves its expression in bone marrow-derived cells","volume":"23","author":"Covey","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1895","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.ATV.20.3.721","article-title":"Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse","volume":"20","author":"Kozarsky","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb1900","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1074\/jbc.274.4.2366","article-title":"Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene","volume":"274","author":"Arai","year":"1999","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1905","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/hep.26316","article-title":"Scavenger receptor BI and ABCG5\/G8 differentially impact biliary sterol secretion and reverse cholesterol transport in mice","volume":"58","author":"Dikkers","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb1910","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/hep.23112","article-title":"Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5\/g8 in mice","volume":"50","author":"Wiersma","year":"2009","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb1915","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1194\/jlr.M038877","article-title":"Scavenger receptor-BI is a receptor for lipoprotein(a)","volume":"54","author":"Yang","year":"2013","journal-title":"J Lipid Res"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb1920","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/embo-reports\/kvf238","article-title":"Liver receptor homolog 1 controls the expression of the scavenger receptor class B type I","volume":"3","author":"Schoonjans","year":"2002","journal-title":"EMBO Rep"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1925","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0006-291X(02)02760-2","article-title":"Oxysterol-activated LXRalpha\/RXR induces hSR-BI-promoter activity in hepatoma cells and preadipocytes","volume":"299","author":"Maler\u00f8d","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1930","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s12020-008-9142-2","article-title":"Human scavenger receptor class B type 1 is regulated by activators of peroxisome proliferators-activated receptor-gamma in hepatocytes","volume":"35","author":"Ahmed","year":"2009","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb1935","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0006-291X(03)00819-2","article-title":"Hepatic scavenger receptor class B, type I is stimulated by peroxisome proliferator-activated receptor gamma and hepatocyte nuclear factor 4alpha","volume":"305","author":"Maler\u00f8d","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1940","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.atherosclerosis.2010.09.016","article-title":"Upregulation of scavenger receptor class B type I expression by activation of FXR in hepatocyte","volume":"213","author":"Chao","year":"2010","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb1945","first-page":"1927","article-title":"Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR","volume":"43","author":"Dong","year":"2019","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.plipres.2021.101109_bb1950","doi-asserted-by":"crossref","first-page":"164925","DOI":"10.1155\/2011\/164925","article-title":"Upregulation of scavenger receptor bi by hepatic nuclear factor 4\u03b1 through a peroxisome proliferator-activated receptor \u03b3-dependent mechanism in liver","volume":"2011","author":"Zhang","year":"2011","journal-title":"PPAR Res"},{"issue":"29","key":"10.1016\/j.plipres.2021.101109_bb1955","doi-asserted-by":"crossref","first-page":"22512","DOI":"10.1074\/jbc.M001631200","article-title":"Transcriptional regulation of rat scavenger receptor class B type I gene","volume":"275","author":"Mizutani","year":"2000","journal-title":"J Biol Chem"},{"issue":"9 Pt A","key":"10.1016\/j.plipres.2021.101109_bb1960","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.bbalip.2016.06.001","article-title":"Low-density lipoprotein upregulate SR-BI through Sp1 Ser702 phosphorylation in hepatic cells","volume":"1861","author":"Yang","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb1965","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/oby.2007.534","article-title":"Impact of vitamin A on high-density lipoprotein-cholesterol and scavenger receptor class BI in the obese rat","volume":"15","author":"Jeyakumar","year":"2007","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb1970","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1210\/en.2004-0330","article-title":"Insulin-like growth factor-i regulation of hepatic scavenger receptor class BI","volume":"145","author":"Cao","year":"2004","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb1975","doi-asserted-by":"crossref","first-page":"E78","DOI":"10.1152\/ajpendo.00023.2007","article-title":"Hyperglycemia suppresses hepatic scavenger receptor class B type I expression","volume":"294","author":"Murao","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1980","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/S0022-2275(20)32218-5","article-title":"Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines","volume":"42","author":"Khovidhunkit","year":"2001","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb1985","doi-asserted-by":"crossref","first-page":"7884","DOI":"10.1074\/jbc.M211627200","article-title":"Fibrates down-regulate hepatic scavenger receptor class B type I protein expression in mice","volume":"278","author":"Mardones","year":"2003","journal-title":"J Biol Chem"},{"issue":"24","key":"10.1016\/j.plipres.2021.101109_bb1990","doi-asserted-by":"crossref","first-page":"23390","DOI":"10.1074\/jbc.M502777200","article-title":"Fenofibrate induces a novel degradation pathway for scavenger receptor B-I independent of PDZK1","volume":"280","author":"Lan","year":"2005","journal-title":"J Biol Chem"},{"issue":"29","key":"10.1016\/j.plipres.2021.101109_bb1995","doi-asserted-by":"crossref","first-page":"10297","DOI":"10.1073\/pnas.0504379102","article-title":"Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice","volume":"102","author":"Johansson","year":"2005","journal-title":"Proceed Nat Acad Sci USA"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb2000","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008722","article-title":"The liver-selective thyromimetic T-0681 influences reverse cholesterol transport and atherosclerosis development in mice","volume":"5","author":"Tancevski","year":"2010","journal-title":"PLoS One"},{"issue":"38","key":"10.1016\/j.plipres.2021.101109_bb2005","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1073\/pnas.0506679102","article-title":"Regulation of SR-BI protein levels by phosphorylation of its associated protein, PDZK1","volume":"102","author":"Nakamura","year":"2005","journal-title":"Proceed Nat Acad Sci USA"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb2010","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.ATV.0000185834.98941.3d","article-title":"Probucol enhances the expression of human hepatic scavenger receptor class B type I, possibly through a species-specific mechanism","volume":"25","author":"Hirano","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"45","key":"10.1016\/j.plipres.2021.101109_bb2015","doi-asserted-by":"crossref","first-page":"34999","DOI":"10.1074\/jbc.M110.164418","article-title":"In vitro and in vivo analysis of the binding of the C terminus of the HDL receptor scavenger receptor class B, type I (SR-BI), to the PDZ1 domain of its adaptor protein PDZK1","volume":"285","author":"Kocher","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb2020","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MOL.0b013e32832aee82","article-title":"Role of the adaptor protein PDZK1 in controlling the HDL receptor SR-BI","volume":"20","author":"Kocher","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.plipres.2021.101109_bb2025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.atherosclerosis.2018.01.045","article-title":"MicroRNA-24 aggravates atherosclerosis by inhibiting selective lipid uptake from HDL cholesterol via the post-transcriptional repression of scavenger receptor class B type I","volume":"270","author":"Ren","year":"2018","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb2030","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1128\/MCB.01580-12","article-title":"MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition","volume":"33","author":"Wang","year":"2013","journal-title":"Mol Cell Biol"},{"issue":"16","key":"10.1016\/j.plipres.2021.101109_bb2035","doi-asserted-by":"crossref","first-page":"11416","DOI":"10.1074\/jbc.M112.437368","article-title":"Regulation of expression and function of scavenger receptor class B, type I (SR-BI) by Na+\/H+ exchanger regulatory factors (NHERFs)","volume":"288","author":"Hu","year":"2013","journal-title":"J Biol Chem"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb2040","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1210\/en.2007-0376","article-title":"Regulation of alternative splicing of liver scavenger receptor class B gene by estrogen and the involved regulatory splicing factors","volume":"148","author":"Zhang","year":"2007","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.plipres.2021.101109_bb2045","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1161\/01.ATV.0000233335.26362.37","article-title":"Phosphatidylinositol-3-kinase regulates scavenger receptor class B type I subcellular localization and selective lipid uptake in hepatocytes","volume":"26","author":"Shetty","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"26","key":"10.1016\/j.plipres.2021.101109_bb2050","doi-asserted-by":"crossref","first-page":"23077","DOI":"10.1074\/jbc.M111.236398","article-title":"Ras\/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI","volume":"286","author":"Wood","year":"2011","journal-title":"J Biol Chem"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb2055","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0022-2275(20)32360-9","article-title":"Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates","volume":"41","author":"Lee","year":"2000","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb2060","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0022-2275(20)40066-5","article-title":"Tissue specific changes in acyl-CoA: cholesterol acyltransferase (ACAT) mRNA levels in rabbits","volume":"36","author":"Pape","year":"1995","journal-title":"J Lipid Res"},{"issue":"44","key":"10.1016\/j.plipres.2021.101109_bb2065","doi-asserted-by":"crossref","first-page":"26192","DOI":"10.1074\/jbc.270.44.26192","article-title":"Tissue-specific expression and cholesterol regulation of acylcoenzyme A:cholesterol acyltransferase (ACAT) in mice. Molecular cloning of mouse ACAT cDNA, chromosomal localization, and regulation of ACAT in vivo and in vitro","volume":"270","author":"Uelmen","year":"1995","journal-title":"J Biol Chem"},{"issue":"41","key":"10.1016\/j.plipres.2021.101109_bb2070","doi-asserted-by":"crossref","first-page":"26747","DOI":"10.1074\/jbc.273.41.26747","article-title":"Identification of a form of acyl-CoA:cholesterol acyltransferase specific to liver and intestine in nonhuman primates","volume":"273","author":"Anderson","year":"1998","journal-title":"J Biol Chem"},{"issue":"36","key":"10.1016\/j.plipres.2021.101109_bb2075","doi-asserted-by":"crossref","first-page":"28083","DOI":"10.1074\/jbc.M003927200","article-title":"Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine","volume":"275","author":"Chang","year":"2000","journal-title":"J Biol Chem"},{"issue":"14","key":"10.1016\/j.plipres.2021.101109_bb2080","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/01.CIR.0000143163.76212.0B","article-title":"ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver","volume":"110","author":"Parini","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb2085","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1091\/mbc.e02-11-0725","article-title":"Human acyl-coenzyme A:cholesterol acyltransferase expressed in chinese hamster ovary cells: membrane topology and active site location","volume":"14","author":"Lin","year":"2003","journal-title":"Mol Biol Cell"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb2090","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1091\/mbc.11.11.3675","article-title":"ACAT1 and ACAT2 membrane topology segregates a serine residue essential for activity to opposite sides of the endoplasmic reticulum membrane","volume":"11","author":"Joyce","year":"2000","journal-title":"Mol Biol Cell"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb2095","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1194\/jlr.M800131-JLR200","article-title":"Identification of putative active site residues of ACAT enzymes","volume":"49","author":"Das","year":"2008","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb2100","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/01.RES.0000147558.15554.67","article-title":"Plasma cholesteryl esters provided by lecithin:cholesterol acyltransferase and acyl-coenzyme a:cholesterol acyltransferase 2 have opposite atherosclerotic potential","volume":"95","author":"Lee","year":"2004","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb2105","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1194\/jlr.M700109-JLR200","article-title":"ACAT2 stimulates cholesteryl ester secretion in apoB-containing lipoproteins","volume":"48","author":"Temel","year":"2007","journal-title":"J Lipid Res"},{"issue":"19","key":"10.1016\/j.plipres.2021.101109_bb2110","doi-asserted-by":"crossref","first-page":"14267","DOI":"10.1074\/jbc.M110.118422","article-title":"Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization","volume":"285","author":"Alger","year":"2010","journal-title":"J Biol Chem"},{"issue":"967","key":"10.1016\/j.plipres.2021.101109_bb2115","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1136\/pgmj.2005.042200","article-title":"Treatment of non-alcoholic fatty liver disease","volume":"82","author":"Adams","year":"2006","journal-title":"Postgrad Med J"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb2120","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1194\/jlr.M024356","article-title":"Tissue-specific knockouts of ACAT2 reveal that intestinal depletion is sufficient to prevent diet-induced cholesterol accumulation in the liver and blood","volume":"53","author":"Zhang","year":"2012","journal-title":"J Lipid Res"},{"issue":"16","key":"10.1016\/j.plipres.2021.101109_bb2125","doi-asserted-by":"crossref","first-page":"10522","DOI":"10.1074\/jbc.M707659200","article-title":"Targeted depletion of hepatic ACAT2-driven cholesterol esterification reveals a non-biliary route for fecal neutral sterol loss","volume":"283","author":"Brown","year":"2008","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb2130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098953","article-title":"Acute sterol o-acyltransferase 2 (SOAT2) knockdown rapidly mobilizes hepatic cholesterol for fecal excretion","volume":"9","author":"Marshall","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb2135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093552","article-title":"Hepatic ACAT2 knock down increases ABCA1 and modifies HDL metabolism in mice","volume":"9","author":"Pedrelli","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb2140","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.dld.2018.12.007","article-title":"Genetic depletion of Soat2 diminishes hepatic steatosis via genes regulating de novo lipogenesis and by GLUT2 protein in female mice","volume":"51","author":"Ahmed","year":"2019","journal-title":"Dig Liver Dis"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb2145","first-page":"166","article-title":"Psidium guajava Linn. leaf extract affects hepatic glucose transporter-2 to attenuate early onset of insulin resistance consequent to high fructose intake: an experimental study","volume":"7","author":"Mathur","year":"2015","journal-title":"Pharm Res"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb2150","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20182129","article-title":"Acyl-CoA: cholesterol acyltransferases-2 gene polymorphism is associated with increased susceptibility to coronary artery disease in Uygur population in Xinjiang, China","volume":"39","author":"Wang","year":"2019","journal-title":"Biosci Rep"},{"issue":"3-4","key":"10.1016\/j.plipres.2021.101109_bb2155","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00439-005-0055-3","article-title":"Acyl-CoA: cholesterol acyltransferase-2 gene polymorphisms and their association with plasma lipids and coronary artery disease risks","volume":"118","author":"He","year":"2005","journal-title":"Hum Genet"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb2160","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1553-2712.2012.01378.x","article-title":"Cholesteryl esters associated with acyl-CoA:cholesterol acyltransferase predict coronary artery disease in patients with symptoms of acute coronary syndrome","volume":"19","author":"Miller","year":"2012","journal-title":"Acad Emerg Med"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb2165","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1073\/pnas.0336398100","article-title":"Deficiency of acyl CoA:cholesterol acyltransferase 2 prevents atherosclerosis in apolipoprotein E-deficient mice","volume":"100","author":"Willner","year":"2003","journal-title":"Proceed Nat Acad Sci USA"},{"issue":"10","key":"10.1016\/j.plipres.2021.101109_bb2170","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1161\/CIRCRESAHA.115.304378","article-title":"Cholesterol esters (CE) derived from hepatic sterol O-acyltransferase 2 (SOAT2) are associated with more atherosclerosis than CE from intestinal SOAT2","volume":"115","author":"Zhang","year":"2014","journal-title":"Circ Res"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb2175","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1161\/01.ATV.0000225289.30767.06","article-title":"Liver-specific inhibition of acyl-coenzyme a:cholesterol acyltransferase 2 with antisense oligonucleotides limits atherosclerosis development in apolipoprotein B100-only low-density lipoprotein receptor-\/- mice","volume":"26","author":"Bell","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"16","key":"10.1016\/j.plipres.2021.101109_bb2180","doi-asserted-by":"crossref","first-page":"10453","DOI":"10.1074\/jbc.M709460200","article-title":"Identification of the interaction site within acyl-CoA:cholesterol acyltransferase 2 for the isoform-specific inhibitor pyripyropene A","volume":"283","author":"Das","year":"2008","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb2185","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.atherosclerosis.2009.04.010","article-title":"ACAT2 and human hepatic cholesterol metabolism: identification of important gender-related differences in normolipidemic, non-obese Chinese patients","volume":"207","author":"Parini","year":"2009","journal-title":"Atherosclerosis"},{"issue":"Pt 3","key":"10.1016\/j.plipres.2021.101109_bb2190","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/BJ20051417","article-title":"Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma","volume":"394","author":"Song","year":"2006","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb2195","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/abbs\/gmr102","article-title":"Two novel cis-elements involved in hepatocyte nuclear factor 4\u03b1 regulation of acyl-coenzyme A:cholesterol acyltransferase 2 expression","volume":"44","author":"Zhang","year":"2012","journal-title":"Acta Biochim Biophys Sin"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb2200","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1194\/jlr.M045922","article-title":"TG-interacting factor 1 acts as a transcriptional repressor of sterol O-acyltransferase 2","volume":"55","author":"Pramfalk","year":"2014","journal-title":"J Lipid Res"},{"issue":"43","key":"10.1016\/j.plipres.2021.101109_bb2205","doi-asserted-by":"crossref","first-page":"44938","DOI":"10.1074\/jbc.M408507200","article-title":"Overexpression of human diacylglycerol acyltransferase 1, acyl-coa:cholesterol acyltransferase 1, or acyl-CoA:cholesterol acyltransferase 2 stimulates secretion of apolipoprotein B-containing lipoproteins in McA-RH7777 cells","volume":"279","author":"Liang","year":"2004","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb2210","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s11033-018-4186-8","article-title":"Inhibition of miR-486 and miR-92a decreases liver and plasma cholesterol levels by modulating lipid-related genes in hyperlipidemic hamsters","volume":"45","author":"Niculescu","year":"2018","journal-title":"Mol Biol Rep"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb2215","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/ncb3551","article-title":"Cholesterol and fatty acids regulate cysteine ubiquitylation of ACAT2 through competitive oxidation","volume":"19","author":"Wang","year":"2017","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb2220","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.05.020","article-title":"Structural basis of low-pH-dependent lysosomal cholesterol egress by NPC1 and NPC2","volume":"182","author":"Qian","year":"2020","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb2225","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2119\/molmed.2011.00258","article-title":"Glycine N-methyltransferase deficiency affects Niemann-Pick type C2 protein stability and regulates hepatic cholesterol homeostasis","volume":"18","author":"Liao","year":"2012","journal-title":"Mol Med"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb2230","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/hmg\/ddq466","article-title":"Npc1 haploinsufficiency promotes weight gain and metabolic features associated with insulin resistance","volume":"20","author":"Jelinek","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb2235","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/oby.2009.415","article-title":"Decreased Npc1 gene dosage in mice is associated with weight gain","volume":"18","author":"Jelinek","year":"2010","journal-title":"Obesity (Silver Spring, Md)"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb2240","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbalip.2007.02.012","article-title":"Steroidogenic acute regulatory protein (StAR), a novel mitochondrial cholesterol transporter","volume":"1771","author":"Miller","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb2245","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.bbadis.2017.01.026","article-title":"Steroidogenic acute regulatory protein (StAR) overexpression attenuates HFD-induced hepatic steatosis and insulin resistance","volume":"1863","author":"Qiu","year":"2017","journal-title":"Biochim Biophys Acta Mol basis Dis"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb2250","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1002\/jcb.26046","article-title":"Steroidogenic acute regulatory protein (StAR) overexpression reduces inflammation and insulin resistance in obese Mice","volume":"118","author":"Qiu","year":"2017","journal-title":"J Cell Biochem"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb2255","doi-asserted-by":"crossref","first-page":"H677","DOI":"10.1152\/ajpheart.01092.2005","article-title":"Caveolin-1 and regulation of cellular cholesterol homeostasis","volume":"291","author":"Frank","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.plipres.2021.101109_bb2260","doi-asserted-by":"crossref","first-page":"9761539","DOI":"10.1155\/2020\/9761539","article-title":"Role of Caveolin-1 in Diabetes and Its Complications","volume":"2020","author":"Haddad","year":"2020","journal-title":"Oxidative Med Cell Longev"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb2265","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/cas.13659","article-title":"Role of caveolin-1 in hepatocellular carcinoma arising from non-alcoholic fatty liver disease","volume":"109","author":"Takeda","year":"2018","journal-title":"Cancer Sci"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb2270","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41419-020-2295-5","article-title":"Hepatocyte caveolin-1 modulates metabolic gene profiles and functions in non-alcoholic fatty liver disease","volume":"11","author":"Han","year":"2020","journal-title":"Cell Death Dis"},{"issue":"7293","key":"10.1016\/j.plipres.2021.101109_bb2275","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.plipres.2021.101109_bb2280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb2285","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb2290","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb2295","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J Hepatol"},{"issue":"9756","key":"10.1016\/j.plipres.2021.101109_bb2300","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/S0140-6736(10)61272-X","article-title":"Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis","volume":"376","author":"Athyros","year":"2010","journal-title":"Lancet (Lond, Engl)"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb2305","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1016\/j.ijcard.2013.06.024","article-title":"Effect of intensive lipid lowering with atorvastatin on cardiovascular outcomes in coronary heart disease patients with mild-to-moderate baseline elevations in alanine aminotransferase levels","volume":"168","author":"Tikkanen","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.plipres.2021.101109_bb2310","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.metabol.2017.02.014","article-title":"The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An expert panel statement","volume":"71","author":"Athyros","year":"2017","journal-title":"Metab Clin Exp"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb2315","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jhep.2015.05.006","article-title":"Statin use and non-alcoholic steatohepatitis in at risk individuals","volume":"63","author":"Dongiovanni","year":"2015","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.plipres.2021.101109_bb2320","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2174\/1570161115666170621082910","article-title":"Statins: an under-appreciated asset for the prevention and the treatment of NAFLD or NASH and the related cardiovascular risk","volume":"16","author":"Athyros","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"issue":"8","key":"10.1016\/j.plipres.2021.101109_bb2325","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081948","article-title":"Pathophysiological, molecular and therapeutic issues of nonalcoholic fatty liver disease: an overview","volume":"20","author":"Marchisello","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10.1016\/j.plipres.2021.101109_bb2330","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/j.metabol.2008.07.030","article-title":"Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia","volume":"57","author":"Hyogo","year":"2008","journal-title":"Metab Clin Exp"},{"issue":"11","key":"10.1016\/j.plipres.2021.101109_bb2335","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1872-034X.2011.00849.x","article-title":"Efficacy of pitavastatin for the treatment of non-alcoholic steatohepatitis with dyslipidemia: an open-label, pilot study","volume":"41","author":"Hyogo","year":"2011","journal-title":"Hepatol Res"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb2340","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jhep.2018.11.032","article-title":"Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitis","volume":"70","author":"Rinella","year":"2019","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.plipres.2021.101109_bb2345","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jhep.2013.02.005","article-title":"Simvastatin maintains function and viability of steatotic rat livers procured for transplantation","volume":"58","author":"Gracia-Sancho","year":"2013","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb2350","doi-asserted-by":"crossref","first-page":"G724","DOI":"10.1152\/ajpgi.00063.2016","article-title":"Statins improve NASH via inhibition of RhoA and Ras","volume":"311","author":"Schierwagen","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.plipres.2021.101109_bb2355","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12876-015-0248-8","article-title":"Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells","volume":"15","author":"Chong","year":"2015","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb2360","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.numecd.2016.09.011","article-title":"Under-prescription of statins in patients with non-alcoholic fatty liver disease","volume":"27","author":"Del Ben","year":"2017","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb2365","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2007.02.013","article-title":"Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study","volume":"47","author":"Ekstedt","year":"2007","journal-title":"J Hepatol"},{"issue":"13","key":"10.1016\/j.plipres.2021.101109_bb2370","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/hepr.12887","article-title":"Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis","volume":"47","author":"Nakade","year":"2017","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.plipres.2021.101109_bb2375","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s00125-013-3149-9","article-title":"The effects of ezetimibe on non-alcoholic fatty liver disease and glucose metabolism: a randomised controlled trial","volume":"57","author":"Takeshita","year":"2014","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.plipres.2021.101109_bb2380","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/hep.27647","article-title":"Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial)","volume":"61","author":"Loomba","year":"2015","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"10.1016\/j.plipres.2021.101109_bb2385","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3904\/kjim.2017.194","article-title":"Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis","volume":"34","author":"Lee","year":"2019","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.plipres.2021.101109_bb2390","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00535-010-0291-8","article-title":"Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease","volume":"46","author":"Park","year":"2011","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.plipres.2021.101109_bb2395","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.freeradbiomed.2016.09.009","article-title":"Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis","volume":"99","author":"Lee","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"29","key":"10.1016\/j.plipres.2021.101109_bb2400","doi-asserted-by":"crossref","first-page":"5664","DOI":"10.1016\/j.febslet.2007.11.023","article-title":"Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome","volume":"581","author":"Deushi","year":"2007","journal-title":"FEBS Lett"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782721000254?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163782721000254?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:43:38Z","timestamp":1759013018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163782721000254"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":480,"alternative-id":["S0163782721000254"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2021.101109","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2021.101109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101109"}}